Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	CLPP BRIP1 ATP6V0A1 RTEL1 WRNIP1 ABCA10 BPTF MLH1 ATP6V0D2 HSPA1L DDX11L8 VCP SLC27A2 TTF2 DDX17 DNAH2 ABCC5 ABCC11 DNAH7 ATP8B2 ATP10D KIF7 DNAH12 MYO1F DDX25 MACF1 ATP2A3	8.86e-09	614	243	27	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	BRIP1 RTEL1 WRNIP1 ABCA10 MLH1 HSPA1L DDX11L8 VCP DDX17 DNAH2 ABCC5 ABCC11 DNAH7 ATP8B2 ATP10D KIF7 DNAH12 DDX25 MACF1 ATP2A3	5.11e-07	441	243	20	GO:0016887
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	BRIP1 RTEL1 WRNIP1 RGS9 ABCA10 GUF1 SEPTIN3 MLH1 HSPA1L DDX11L8 VCP RAB25 DDX17 DNAH2 ABCC5 ABCC11 DNAH7 ATP8B2 ATP10D KIF7 DNAH12 DDX25 MACF1 ATP2A3	2.79e-05	775	243	24	GO:0017111
GeneOntologyMolecularFunction	peptidyltransferase activity	GGT1 GGT3P GGT2P	3.47e-05	6	243	3	GO:0000048
GeneOntologyMolecularFunction	leukotriene-C(4) hydrolase	GGT1 GGT3P GGT2P	3.47e-05	6	243	3	GO:0002951
GeneOntologyMolecularFunction	leukotriene C4 gamma-glutamyl transferase activity	GGT1 GGT3P GGT2P	9.53e-05	8	243	3	GO:0103068
GeneOntologyMolecularFunction	pyrophosphatase activity	BRIP1 RTEL1 WRNIP1 RGS9 ABCA10 GUF1 SEPTIN3 MLH1 HSPA1L DDX11L8 VCP RAB25 DDX17 DNAH2 ABCC5 ABCC11 DNAH7 ATP8B2 ATP10D KIF7 DNAH12 DDX25 MACF1 ATP2A3	9.66e-05	839	243	24	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	BRIP1 RTEL1 WRNIP1 RGS9 ABCA10 GUF1 SEPTIN3 MLH1 HSPA1L DDX11L8 VCP RAB25 DDX17 DNAH2 ABCC5 ABCC11 DNAH7 ATP8B2 ATP10D KIF7 DNAH12 DDX25 MACF1 ATP2A3	9.84e-05	840	243	24	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	BRIP1 RTEL1 WRNIP1 RGS9 ABCA10 GUF1 SEPTIN3 MLH1 HSPA1L DDX11L8 VCP RAB25 DDX17 DNAH2 ABCC5 ABCC11 DNAH7 ATP8B2 ATP10D KIF7 DNAH12 DDX25 MACF1 ATP2A3	9.84e-05	840	243	24	GO:0016818
GeneOntologyMolecularFunction	glutathione hydrolase activity	GGT1 GGT3P GGT2P	1.42e-04	9	243	3	GO:0036374
GeneOntologyMolecularFunction	transmembrane transporter binding	SRI ACTN4 ACTN1 ACTN2 S100A10 TJP2 ATP2A3 SNTA1 HTT	2.66e-04	172	243	9	GO:0044325
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	BRIP1 RTEL1 WRNIP1 GGT1 GGT3P RPP25 BPTF MLH1 CARS2 DDX11L8 TTF2 DDX17 POLG SLU7 GGT2P TOE1 CNOT6L N4BP2 DDX25	3.66e-04	645	243	19	GO:0140640
GeneOntologyMolecularFunction	coumarin 7-hydroxylase activity	CYP2A6 CYP2A13	4.39e-04	3	243	2	GO:0008389
GeneOntologyMolecularFunction	adenosine-phosphate deaminase activity	AMPD1 AMPD3	4.39e-04	3	243	2	GO:0047623
GeneOntologyMolecularFunction	AMP deaminase activity	AMPD1 AMPD3	4.39e-04	3	243	2	GO:0003876
GeneOntologyMolecularFunction	actin filament binding	SPTB ACTN4 ACTN1 ACTN2 NEB ADD2 FGD4 FMNL1 MYO1F MACF1	4.85e-04	227	243	10	GO:0051015
GeneOntologyMolecularFunction	molecular adaptor activity	DCAF1 ZSWIM8 ASXL1 ACTN4 ACTN1 ACTN2 DDB1 SEPTIN3 AP2B1 TJP2 HTATSF1 CAMTA1 PIH1D1 FEM1A VCP STRN3 DDX17 TANK SASH1 IFI16 SUV39H2 SH2B1 STRIP1 KMT2D FXR1 EPC1 OTUD4 SMARCC2 GIGYF2 STX10 PCNT	5.30e-04	1356	243	31	GO:0060090
GeneOntologyMolecularFunction	actin binding	MYLK MAP2 SPTB ACTN4 ACTN1 ACTN2 NEB ADD2 FGD4 UTRN FMNL1 KLHL5 MYO1F MACF1 SNTA1	8.22e-04	479	243	15	GO:0003779
GeneOntologyMolecularFunction	omega peptidase activity	GGT1 GGT3P GGT2P	8.87e-04	16	243	3	GO:0008242
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	BRIP1 RTEL1 WRNIP1 BPTF MLH1 DDX11L8 TTF2	9.40e-04	127	243	7	GO:0008094
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH2 DNAH7 DNAH12 HTT	1.03e-03	37	243	4	GO:0045505
GeneOntologyMolecularFunction	cell adhesion molecule binding	OBSCN CKAP5 EXOC3 ACTN4 ACTN1 ACTN2 EHD4 BMPR2 PTPRM PTPRZ1 TJP2 UTRN DSCAM GIGYF2 MACF1 BZW1 TJP3	1.12e-03	599	243	17	GO:0050839
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH2 DNAH7 DNAH12	1.27e-03	18	243	3	GO:0008569
GeneOntologyMolecularFunction	cytoskeletal regulatory protein binding	MAP2 ACTN1	1.44e-03	5	243	2	GO:0005519
GeneOntologyMolecularFunction	histone H3K9 trimethyltransferase activity	PRDM2 SUV39H2	1.44e-03	5	243	2	GO:0140949
GeneOntologyMolecularFunction	GTPase binding	SYTL2 BCL2L1 GIT2 TBC1D20 FGD4 FMNL1 DOCK3 STRN3 CCDC186 POU4F1 CYRIB STRIP1	1.60e-03	360	243	12	GO:0051020
GeneOntologyMolecularFunction	threonine-type peptidase activity	GGT1 GGT3P GGT2P	1.74e-03	20	243	3	GO:0070003
GeneOntologyCellularComponent	pseudopodium	ACTN4 ACTN1 ACTN2 RAB25	4.72e-05	18	242	4	GO:0031143
GeneOntologyCellularComponent	inner dynein arm	DNAH2 DNAH7 DNAH12	1.73e-04	10	242	3	GO:0036156
GeneOntologyCellularComponent	spliceosomal complex	SREK1 ADAR SF3A3 HTATSF1 TTF2 PNN GPATCH1 SLU7 BUD13 PPWD1	2.13e-04	215	242	10	GO:0005681
MousePheno	ovary hypoplasia	GGT1 GGT3P GGT2P SH2B1	7.37e-06	10	196	4	MP:0005158
MousePheno	absent tertiary ovarian follicles	GGT1 GGT3P GGT2P SH2B1	1.15e-05	11	196	4	MP:0011130
MousePheno	abnormal circulating glutathione level	GGT1 GGT3P GGT2P	2.66e-05	5	196	3	MP:0030652
MousePheno	increased circulating glutathione level	GGT1 GGT3P GGT2P	2.66e-05	5	196	3	MP:0030653
MousePheno	glutathionuria	GGT1 GGT3P GGT2P	2.66e-05	5	196	3	MP:0013730
MousePheno	increased glutathione level	GGT1 GGT3P GGT2P	2.66e-05	5	196	3	MP:0012606
MousePheno	decreased spleen red pulp amount	ASXL1 GGT1 GGT3P GGT2P	5.98e-05	16	196	4	MP:0008477
MousePheno	abnormal reproductive system development	BRIP1 ACVR2A GGT1 GGT3P GREB1L GGT2P SH2B1 KIF7	7.45e-05	99	196	8	MP:0003936
MousePheno	decreased circulating cysteine level	GGT1 GGT3P GGT2P	9.12e-05	7	196	3	MP:0030626
MousePheno	decreased cysteine level	GGT1 GGT3P GGT2P	1.44e-04	8	196	3	MP:0030623
MousePheno	epididymis hypoplasia	GGT1 GGT3P GGT2P	1.44e-04	8	196	3	MP:0004932
Domain	Spectrin	SPTB ACTN4 ACTN1 ACTN2 UTRN MACF1	3.56e-07	23	240	6	PF00435
Domain	ACTININ_2	SPTB ACTN4 ACTN1 ACTN2 UTRN MACF1	3.56e-07	23	240	6	PS00020
Domain	ACTININ_1	SPTB ACTN4 ACTN1 ACTN2 UTRN MACF1	3.56e-07	23	240	6	PS00019
Domain	Actinin_actin-bd_CS	SPTB ACTN4 ACTN1 ACTN2 UTRN MACF1	3.56e-07	23	240	6	IPR001589
Domain	Spectrin_repeat	SPTB ACTN4 ACTN1 ACTN2 UTRN MACF1	1.57e-06	29	240	6	IPR002017
Domain	SPEC	SPTB ACTN4 ACTN1 ACTN2 UTRN MACF1	2.90e-06	32	240	6	SM00150
Domain	Spectrin/alpha-actinin	SPTB ACTN4 ACTN1 ACTN2 UTRN MACF1	2.90e-06	32	240	6	IPR018159
Domain	EFhand_Ca_insen	ACTN4 ACTN1 ACTN2	4.07e-05	6	240	3	PF08726
Domain	EF-hand_Ca_insen	ACTN4 ACTN1 ACTN2	4.07e-05	6	240	3	IPR014837
Domain	-	BRIP1 RTEL1 WRNIP1 ABCA10 EHD4 GUF1 SEPTIN3 TJP2 NLRC5 HS3ST4 VCP TTF2 RAB25 DDX17 DNAH2 ABCC5 ABCC11 DNAH7 DNAH12 N4BP2 MYO1F DDX25 TJP3	9.91e-05	746	240	23	3.40.50.300
Domain	P-loop_NTPase	BRIP1 RTEL1 WRNIP1 ABCA10 EHD4 GUF1 SEPTIN3 TJP2 NLRC5 CAMTA1 HS3ST4 VCP TTF2 RAB25 DDX17 DNAH2 ABCC5 ABCC11 DNAH7 KIF7 DNAH12 N4BP2 MYO1F DDX25 TJP3	9.96e-05	848	240	25	IPR027417
Domain	-	SRI DGKG ACTN4 ACTN1 ACTN2 STAT2 EHD4 S100A10 PLCL1 UTRN MACF1 MICU2	1.49e-04	261	240	12	1.10.238.10
Domain	CH	SPTB ACTN4 ACTN1 ACTN2 UTRN MACF1	1.85e-04	65	240	6	SM00033
Domain	CH	SPTB ACTN4 ACTN1 ACTN2 UTRN MACF1	2.79e-04	70	240	6	PF00307
Domain	-	SPTB ACTN4 ACTN1 ACTN2 UTRN MACF1	3.02e-04	71	240	6	1.10.418.10
Domain	CH	SPTB ACTN4 ACTN1 ACTN2 UTRN MACF1	3.51e-04	73	240	6	PS50021
Domain	EF-hand-dom_pair	SRI DGKG ACTN4 ACTN1 ACTN2 STAT2 EHD4 S100A10 PLCL1 UTRN MACF1 MICU2	3.56e-04	287	240	12	IPR011992
Domain	CH-domain	SPTB ACTN4 ACTN1 ACTN2 UTRN MACF1	4.06e-04	75	240	6	IPR001715
Domain	ARM-type_fold	DCAF1 GBF1 CKAP5 ELMO1 NF1 AP2B1 TAF2 FMNL1 DOCK3 RELCH BZW1 STAG3 HTT	4.66e-04	339	240	13	IPR016024
Domain	AMPD	AMPD1 AMPD3	4.89e-04	3	240	2	IPR006329
Domain	ZO	TJP2 TJP3	4.89e-04	3	240	2	IPR005417
Domain	K_chnl_volt-dep_ERG	KCNH6 KCNH2	4.89e-04	3	240	2	IPR003967
Domain	AAA+_ATPase	WRNIP1 ABCA10 VCP DNAH2 ABCC5 ABCC11 DNAH7 DNAH12	5.56e-04	144	240	8	IPR003593
Domain	AAA	WRNIP1 ABCA10 VCP DNAH2 ABCC5 ABCC11 DNAH7 DNAH12	5.56e-04	144	240	8	SM00382
Domain	AAA_8	DNAH2 DNAH7 DNAH12	6.87e-04	14	240	3	PF12780
Domain	Dynein_heavy_chain_D4_dom	DNAH2 DNAH7 DNAH12	6.87e-04	14	240	3	IPR024317
Domain	Dynein_heavy_dom-2	DNAH2 DNAH7 DNAH12	6.87e-04	14	240	3	IPR013602
Domain	DHC_N2	DNAH2 DNAH7 DNAH12	6.87e-04	14	240	3	PF08393
Domain	DHC_fam	DNAH2 DNAH7 DNAH12	8.50e-04	15	240	3	IPR026983
Domain	Dynein_heavy	DNAH2 DNAH7 DNAH12	8.50e-04	15	240	3	PF03028
Domain	Dynein_heavy_dom	DNAH2 DNAH7 DNAH12	8.50e-04	15	240	3	IPR004273
Domain	EF_hand_dom	SRI DGKG ACTN4 ACTN1 ACTN2 EHD4 S100A10 DNAH7 MACF1 MICU2	8.68e-04	232	240	10	IPR002048
Domain	Cyt_P450_E_grp-I_CYP2A-like	CYP2A6 CYP2A13	9.70e-04	4	240	2	IPR008067
Domain	DEAD_2	BRIP1 RTEL1	9.70e-04	4	240	2	PF06733
Domain	DNA_helicase_DNA-repair_Rad3	BRIP1 RTEL1	9.70e-04	4	240	2	IPR013020
Domain	Aldolase_II	ADD2 APIP	9.70e-04	4	240	2	SM01007
Domain	PP2A_PR55	PPP2R2D PPP2R2C	9.70e-04	4	240	2	IPR000009
Domain	Aldolase_II/adducin_N	ADD2 APIP	9.70e-04	4	240	2	IPR001303
Domain	HIN200/IF120x	PYHIN1 IFI16	9.70e-04	4	240	2	IPR004021
Domain	A/AMP_deam_AS	AMPD1 AMPD3	9.70e-04	4	240	2	IPR006650
Domain	DEXDc2	BRIP1 RTEL1	9.70e-04	4	240	2	SM00488
Domain	HELICc2	BRIP1 RTEL1	9.70e-04	4	240	2	SM00491
Domain	PR55_2	PPP2R2D PPP2R2C	9.70e-04	4	240	2	PS01025
Domain	PR55_1	PPP2R2D PPP2R2C	9.70e-04	4	240	2	PS01024
Domain	HIN_200	PYHIN1 IFI16	9.70e-04	4	240	2	PS50834
Domain	PP2A_PR55_CS	PPP2R2D PPP2R2C	9.70e-04	4	240	2	IPR018067
Domain	Helicase_C_2	BRIP1 RTEL1	9.70e-04	4	240	2	PF13307
Domain	DEAD_2	BRIP1 RTEL1	9.70e-04	4	240	2	IPR010614
Domain	ATP-dep_Helicase_C	BRIP1 RTEL1	9.70e-04	4	240	2	IPR006555
Domain	Helicase-like_DEXD_c2	BRIP1 RTEL1	9.70e-04	4	240	2	IPR006554
Domain	Aldolase_II	ADD2 APIP	9.70e-04	4	240	2	PF00596
Domain	HELICASE_ATP_BIND_2	BRIP1 RTEL1	9.70e-04	4	240	2	PS51193
Domain	HIN	PYHIN1 IFI16	9.70e-04	4	240	2	PF02760
Domain	-	ADD2 APIP	9.70e-04	4	240	2	3.40.225.10
Domain	Helic_SF1/SF2_ATP-bd_DinG/Rad3	BRIP1 RTEL1	9.70e-04	4	240	2	IPR014013
Domain	Carb_anhydrase	PTPRZ1 CA2 CA5B	1.25e-03	17	240	3	PF00194
Domain	Carb_anhydrase	PTPRZ1 CA2 CA5B	1.25e-03	17	240	3	SM01057
Domain	-	PTPRZ1 CA2 CA5B	1.25e-03	17	240	3	3.10.200.10
Domain	ALPHA_CA_2	PTPRZ1 CA2 CA5B	1.25e-03	17	240	3	PS51144
Domain	Ald_DH_CS_CYS	ALDH1B1 ALDH1A3 ALDH6A1	1.25e-03	17	240	3	IPR016160
Domain	Carbonic_anhydrase_a	PTPRZ1 CA2 CA5B	1.25e-03	17	240	3	IPR001148
Domain	ALDEHYDE_DEHYDR_GLU	ALDH1B1 ALDH1A3 ALDH6A1	1.48e-03	18	240	3	PS00687
Domain	ALDEHYDE_DEHYDR_CYS	ALDH1B1 ALDH1A3 ALDH6A1	1.48e-03	18	240	3	PS00070
Domain	Aldedh	ALDH1B1 ALDH1A3 ALDH6A1	1.74e-03	19	240	3	PF00171
Domain	Aldehyde_DH_dom	ALDH1B1 ALDH1A3 ALDH6A1	1.74e-03	19	240	3	IPR015590
Domain	-	ALDH1B1 ALDH1A3 ALDH6A1	1.74e-03	19	240	3	3.40.309.10
Domain	-	ALDH1B1 ALDH1A3 ALDH6A1	1.74e-03	19	240	3	3.40.605.10
Domain	Ald_DH_C	ALDH1B1 ALDH1A3 ALDH6A1	1.74e-03	19	240	3	IPR016163
Domain	Ald_DH_N	ALDH1B1 ALDH1A3 ALDH6A1	1.74e-03	19	240	3	IPR016162
Domain	Ald_DH/histidinol_DH	ALDH1B1 ALDH1A3 ALDH6A1	1.74e-03	19	240	3	IPR016161
Pathway	REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION	CYP2A6 CYP2A13 GGT1 GGT3P GGT2P	2.38e-05	26	193	5	MM15190
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ATP6V0A1 MAP2 PPP1R12B SPTB COPB2 WRNIP1 CKAP5 ACTN4 ACTN1 ACTN2 NDUFB7 DDB1 ADD2 NF1 AP2B1 FGD4 PTPRZ1 SPON1 TJP2 PLCL1 ALDH1B1 UTRN SDHA VCP CA2 STRN3 DDX17 ARHGEF12 CYRIB STRIP1 PPP2R2C FXR1 SUGP2 EIF2S1 VCAN OTUD4 SMARCC2 MACF1 SNTA1	4.53e-13	1431	245	39	37142655
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	ATP6V0A1 MYLK ADAM21 PPP1R12B BCL2L1 DPP8 GGT1 KCNH6 KCNA10 AP2B1 KCNH2 ECEL1 PLCL1 CARS2 STRN3 RIOK1 DDX17 DNAH2 PPWD1 SUV39H2 GGT2P KLHL5 SEPHS1 CSNK1E DGKK	9.56e-11	730	245	25	34857952
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DCAF1 CASP14 COPB2 CKAP5 EXOC3 ACTN4 ACTN1 ADAR BIRC6 DDB1 EHD4 GUF1 NF1 ADSL AP2B1 SF3A3 MLH1 TAF2 ALDH1B1 HSPA1L UTRN VCP TTF2 DDX17 PNN SLU7 IFI16 TOE1 ESF1 FXR1 SUGP2 EIF2S1 SMARCC2 MACF1	1.46e-10	1353	245	34	29467282
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CYP2A6 CYP2A13 DENND4A MYLK PPP1R12B ACTN4 ACTN1 ACTN2 SREK1 NEB NUP54 EHD4 BPTF AP2B1 GPC4 DLEC1 ALDH1B1 HSPA1L STRN3 DDX17 PNN DNAH2 ABCC5 ESF1 SEPHS1 FXR1 N4BP2 DGKK SMARCC2 MACF1 UGGT2 ATP2A3 DOP1A PCNT	7.58e-10	1442	245	34	35575683
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CLPP DCAF1 POGLUT3 MCMBP ATP6V0A1 MAP2 EXOC3 MPDZ SREK1 DDB1 ADD2 EHD4 GUF1 TMTC3 P3H1 HTATSF1 EEF2K CARS2 PIH1D1 HSPA1L SDHA VCP SLU7 LAMC1 ESF1 KIF7 EIF2S1 CSNK1E N4BP2 MACF1 UGGT2 TXLNG MAST3 PCNT	1.66e-09	1487	245	34	33957083
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	DCAF1 MCMBP GBF1 PPP2R2D COPB2 WRNIP1 CKAP5 MPDZ ACTN4 NEDD1 DDB1 S100A10 ADSL TMTC3 AP2B1 PTPRM SF3A3 TJP2 UTRN SDHA VCP LAMC1 KIF7 FXR1 CSNK1E BZW1 SNTA1	1.69e-09	974	245	27	28675297
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ZSWIM8 COPB2 CKAP5 ACTN4 ACTN1 BIRC6 DDB1 BPTF NF1 AP2B1 TJP2 UTRN SDHA VCP PNN ESF1 FXR1 SUGP2 SMARCC2 GIGYF2 MACF1 PCNT	1.82e-09	653	245	22	22586326
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ZSWIM8 DCHS2 ATP6V0A1 SPTB SRI CKAP5 ACTN4 ACTN1 NDUFB7 S100A10 GUF1 SEPTIN3 AP2B1 OTOF SYT4 CARS2 UTRN SDHA VCP DOCK3 DSCAM POLG ABCC5 SH2B1 ACAD8 CELSR3 PPP1R16B MACF1 TXLNG SNTA1 PCNT	2.68e-09	1285	245	31	35914814
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DENND4A MCMBP HIVEP1 GBF1 MAP2 CKAP5 MPDZ DPP8 CDK14 DENND2B MOB2 BMPR2 NF1 TJP2 UTRN SASH1 LAMC1 DNAH7 FXR1 CSNK1E N4BP2 GIGYF2 MACF1 DOP1A OTOG	2.81e-09	861	245	25	36931259
Pubmed	Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.	DCAF1 WRNIP1 CKAP5 PYHIN1 GPC4 SF3A3 HTATSF1 ZNF280C SLU7 BUD13 LAMC1 SUGP2 VCAN GIGYF2	3.64e-09	251	245	14	28077445
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	MPDZ ACTN4 ACTN1 ADAR DDB1 TJP2 VCP DDX17 PNN ESF1 FXR1 SUGP2 SMARCC2 GIGYF2	1.11e-08	274	245	14	34244482
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	MCMBP GBF1 MAP2 GON7 COPB2 WRNIP1 ACTN4 ACTN1 DPP8 BIRC6 DDB1 EHD4 RPP25 SEC24D ADSL AP2B1 P3H1 SF3A3 TJP2 HTATSF1 EEF2K ALDH1B1 PIH1D1 HSPA1L VCP STRN3 RELCH DDX17 EIF2S1 MACF1 BZW1 HTT	1.31e-08	1455	245	32	22863883
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	POGLUT3 BRIP1 SYTL2 WRNIP1 MPDZ NEDD1 BIRC6 DDB1 STAT2 TMTC3 SF3A3 TJP2 RIOK1 TANK STRIP1 FXR1 CNOT6L CSNK1E N4BP2 UGGT2 BZW1 C6orf47	1.47e-08	733	245	22	34672954
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CASP14 CKAP5 EXOC3 ACTN4 ACTN1 ADAR DDB1 NUP54 EHD4 BPTF NF1 SF3A3 TJP2 UTRN VCP DDX17 PNN LAMC1 KIF7 FXR1 SUGP2 EIF2S1 SMARCC2 GIGYF2 MACF1 PCNT	2.05e-08	1024	245	26	24711643
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	DENND4A MCMBP ATP6V0A1 HIVEP1 GBF1 COPB2 CKAP5 ACTN4 SREK1 ADAR DDB1 PRDM2 EHD4 NF1 ADSL SF3A3 ALDH1B1 SDHA CA2 RIOK1 DDX17 PNN ZNF280C TOE1 ESF1 FXR1 CLCA2 EIF2S1 CSNK1E GIGYF2 BZW1	2.90e-08	1425	245	31	30948266
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CKAP5 ACTN4 NEDD1 DDB1 S100A10 SIMC1 TJP2 TAF2 ALDH1B1 PIH1D1 TTF2 STRN3 RIOK1 TANK FPGS GPATCH1 DNAH7 KIF7 CSNK1E N4BP2 GIGYF2 TXLNG PCNT	4.82e-08	853	245	23	28718761
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	DENND4A HIVEP1 GBF1 CKAP5 NF1 OTOF TJP2 HTATSF1 FMNL1 DOCK3 PNN ARHGEF12 BUD13 CELSR3 MACF1	5.15e-08	361	245	15	26167880
Pubmed	Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.	CLPP ACP6 POGLUT3 ATP6V0A1 COPB2 SRI OBSCN ACTN4 ACTN1 NDUFB7 RPP25 P3H1 MLH1 ALDH1B1 CARS2 UTRN SDHA VCP CA2 LAMC1 ESF1 BZW1 TXLNG	5.47e-08	859	245	23	31536960
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	NEB ADAR OTOF SDHA DDX17 PNN KLHL5 KMT2D FXR1 SMARCC2 GIGYF2 MACF1	1.21e-07	234	245	12	36243803
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	DCAF1 ACTN2 TAF2 TANK CCDC186 KIF7 PPP2R2C FXR1 GIGYF2 UGGT2 ATP2A3 HTT PCNT	1.40e-07	285	245	13	32838362
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	BRIP1 HIVEP1 GBF1 WRNIP1 CKAP5 PRDM2 BPTF NF1 TJP2 STRN3 PNN BUD13 IFI16 ESF1 STRIP1 KMT2D SUGP2 CSNK1E OTUD4 SMARCC2 GIGYF2	1.71e-07	774	245	21	15302935
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	CASP14 COPB2 ADAR DDB1 SF3A3 HTATSF1 VCP DDX17 PNN TOE1 SUGP2 SMARCC2	1.91e-07	244	245	12	29884807
Pubmed	140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry.	MAP2 CKAP5 BIRC6 ADD2 NF1 SEPTIN3 AP2B1 STRN3 RELCH DDX17	2.69e-07	163	245	10	16512683
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	BRIP1 CASP14 EXOC3 ADAR DDB1 BPTF AP2B1 MLH1 PIH1D1 TTF2 STRN3 ZNF280C SUGP2 EIF2S1 MACF1 BZW1	2.94e-07	472	245	16	38943005
Pubmed	Huntingtin associates with the actin cytoskeleton and α-actinin isoforms to influence stimulus dependent morphology changes.	ACTN1 ACTN2 HTT	3.45e-07	3	245	3	30768638
Pubmed	Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney.	GGT1 GGT3P GGT2P	3.45e-07	3	245	3	2573352
Pubmed	Diverse functions of myosin VI elucidated by an isoform-specific α-helix domain.	DCAF1 COPB2 DDB1 AP2B1 ARHGEF12	3.98e-07	22	245	5	26950368
Pubmed	Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology.	ACTN4 ACTN1 ACTN2 NEB	4.88e-07	10	245	4	20368620
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	ZSWIM8 HIVEP1 WRNIP1 ACTN1 ACTN2 DDB1 NF1 MLH1 VCP RIC3 TANK GPATCH1 LAMC1 KIF7 FXR1 SCMH1 SMARCC2	5.79e-07	560	245	17	21653829
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ASXL1 GBF1 RTEL1 GIT2 BIRC6 SPON1 CAMTA1 PPP1R16B GIGYF2 MACF1 PCNT	6.59e-07	225	245	11	12168954
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	CKAP5 ACTN4 ACTN1 ADAR EHD4 AP2B1 SF3A3 HSPA1L UTRN SDHA TTF2 DDX17 DNAH2 LAMC1 SEPHS1 EIF2S1 SMARCC2 MACF1 TXLNG DOP1A PCNT	7.38e-07	847	245	21	35235311
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	DENND4A GBF1 MPDZ BIRC6 MOB2 NF1 TJP2 UTRN FMNL1 TTF2 STRN3 STRIP1 KIF7 CSNK1E GIGYF2	7.67e-07	446	245	15	24255178
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	DCAF1 ASXL1 MCMBP HIVEP1 CASP14 PPP2R2D WRNIP1 MPDZ ADSL AP2B1 P3H1 SF3A3 TJP2 FEM1A UTRN VCP CA2 STRN3 STRIP1 KIF7 OTUD4 GIGYF2 UGGT2	8.52e-07	1005	245	23	19615732
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	MAP2 ADD2 SEPTIN3 PTPRZ1 GPC4 TJP2 SASH1 EIF2S1 SMARCC2 MACF1 MAST3	8.54e-07	231	245	11	16452087
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	CKAP5 NEDD1 ADAR DDB1 AP2B1 MLH1 HTATSF1 PIH1D1 UTRN VCP TTF2 STRN3 RIOK1 DDX17 PNN GPATCH1 ZNF280C ESF1 SUGP2 GIGYF2 MACF1 PCNT	9.31e-07	934	245	22	33916271
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	MCMBP COPB2 CKAP5 ACTN4 ACTN1 BIRC6 DDB1 S100A10 ADSL AP2B1 SF3A3 HTATSF1 CARS2 PIH1D1 SDHA VCP RIOK1 DDX17 PNN PPWD1 TOE1 FXR1 EIF2S1 SMARCC2 GIGYF2 MACF1 BZW1 TXLNG	9.49e-07	1415	245	28	28515276
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	COPB2 WRNIP1 CKAP5 SREK1 DDB1 EHD4 NF1 SF3A3 MLH1 TTF2 RIOK1 DDX17 PNN SMARCC2 MACF1 BZW1 PCNT	9.81e-07	582	245	17	20467437
Pubmed	Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.	ACTN4 ACTN1 DDB1 AP2B1 TJP2 UTRN SDHA VCP EIF2S1 MACF1	1.15e-06	191	245	10	33762435
Pubmed	Alpha-actinin and vinculin in human neutrophils: reorganization during adhesion and relation to the actin network.	ACTN4 ACTN1 ACTN2	1.37e-06	4	245	3	1629252
Pubmed	Brain-specific regulator of G-protein signaling 9-2 selectively interacts with alpha-actinin-2 to regulate calcium-dependent inactivation of NMDA receptors.	ACTN4 RGS9 ACTN2	1.37e-06	4	245	3	16510730
Pubmed	Molecular structure of the sarcomeric Z-disk: two types of titin interactions lead to an asymmetrical sorting of alpha-actinin.	ACTN1 ACTN2 NEB	1.37e-06	4	245	3	9501083
Pubmed	Disruption of alpha-actinin-integrin interactions at focal adhesions renders osteoblasts susceptible to apoptosis.	ACTN4 ACTN1 ACTN2	1.37e-06	4	245	3	16807302
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	DCAF1 RTEL1 NEB ADAR HSPA1L COL27A1 BCO1 MACF1 HTT	1.44e-06	152	245	9	34299191
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	ACP6 DENND4A GBF1 CDK15 COPB2 GIT2 SREK1 CDK14 EHD4 CFLAR AP2B1 UBAC1 SF3A3 TJP2 HTATSF1 VCP STRN3 RAB25 PNN STRIP1 CNOT6L EIF2S1 CSNK1E OTUD4 BZW1 ATP2A3	1.57e-06	1284	245	26	17353931
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	GBF1 WRNIP1 ACTN4 ACTN1 S100A10 AP2B1 UBAC1 GPC4 VCP SLC27A2 TTF2 LAMC1 OTUD4 MACF1 PCNT	1.95e-06	481	245	15	28190767
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	DCAF1 ASXL1 PPP2R2D PPP1R12B COPB2 CKAP5 EXOC3 NEDD1 DDB1 MOB2 AP2B1 P3H1 SF3A3 HTATSF1 VCP CA2 STRN3 DDX17 BUD13 STRIP1 ACAD8 CNOT6L CSNK1E SMARCC2	2.61e-06	1155	245	24	20360068
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	SP2 COPB2 CKAP5 GIT2 ADAR BPTF ADSL AP2B1 SF3A3 FMNL1 VCP SLU7 SMARCC2	2.63e-06	370	245	13	22922362
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	DENND4A HIVEP1 SPTB OBSCN ACTN4 GIT2 ACTN2 NEB BIRC6 UTRN VCP AMPD1 LAMC1 FSD2 MACF1	2.90e-06	497	245	15	23414517
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	MCMBP CASP14 MPDZ PIH1D1 STRN3 STRIP1 KIF7 SEPHS1 SUGP2 PCNT	2.95e-06	212	245	10	33853758
Pubmed	Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner.	ACTN4 ACTN1 ACTN2	3.42e-06	5	245	3	15841212
Pubmed	Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	12810527
Pubmed	Reproductive defects in gamma-glutamyl transpeptidase-deficient mice.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	11089562
Pubmed	Mice with genetic gamma-glutamyl transpeptidase deficiency exhibit glutathionuria, severe growth failure, reduced life spans, and infertility.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	9139708
Pubmed	Analysis of site-specific glycosylation of renal and hepatic γ-glutamyl transpeptidase from normal human tissue.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	20622017
Pubmed	Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	9546365
Pubmed	gamma-Glutamyl transpeptidase. What does the organization and expression of a multipromoter gene tell us about its functions?	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	7485380
Pubmed	Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	10751614
Pubmed	gamma-Glutamyl transferase (GGT) deficiency in the GGTenu1 mouse results from a single point mutation that leads to a stop codon in the first coding exon of GGT mRNA.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	10474818
Pubmed	Gamma-glutamyltranspeptidase knockout mice as a model for understanding the consequences of diminished glutathione on T cell-dependent immune responses.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	10940879
Pubmed	The mouse skin carcinogenesis model.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	9627710
Pubmed	Gamma-glutamyl transpeptidase and its role in melanogenesis: redox reactions and regulation of tyrosinase.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	12453183
Pubmed	Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	25132819
Pubmed	Phenotypic characterization of Ggt1(dwg/dwg) mice,a mouse model for hereditary γ-glutamyltransferase deficiency.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	23615310
Pubmed	gamma-glutamyltranspeptidase-deficient knockout mice as a model to study the relationship between glutathione status, mitochondrial function, and cellular function.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	11003618
Pubmed	Gamma-glutamyl transpeptidase gene organization and expression: a comparative analysis in rat, mouse, pig and human species.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	10392451
Pubmed	Hyperoxia-induced lung injury in gamma-glutamyl transferase deficiency is associated with alterations in nitrosative and nitrative stress.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	19850887
Pubmed	Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	8755578
Pubmed	N-acetyl-cysteine prevents age-related hearing loss and the progressive loss of inner hair cells in γ-glutamyl transferase 1 deficient mice.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	26977590
Pubmed	Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	12225953
Pubmed	Identification of a sixth promoter that directs the transcription of gamma-glutamyl transpeptidase type III RNA in mouse.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	7775425
Pubmed	The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin.	ACTN4 ACTN1 ACTN2	3.42e-06	5	245	3	12837758
Pubmed	Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	7523374
Pubmed	Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	24698228
Pubmed	Lung lining fluid glutathione attenuates IL-13-induced asthma.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	18063838
Pubmed	Cataract development in gamma-glutamyl transpeptidase-deficient mice.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	11095909
Pubmed	Expression of gamma-glutamyl transpeptidase in midgestation mouse yolk sac and mouse visceral yolk sac carcinoma cells.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	7641802
Pubmed	Immunocytochemical localization of gamma-glutamyltranspeptidase during fetal development of mouse kidney.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	2891746
Pubmed	Liver-Specific Overexpression of Gamma-Glutamyltransferase Ameliorates Insulin Sensitivity of Male C57BL/6 Mice.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	28660214
Pubmed	Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	12468440
Pubmed	Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	8566783
Pubmed	Therapeutic Effect of GGsTop, Selective Gamma-glutamyl Transpeptidase Inhibitor, on a Mouse Model of 5-Fluorouracil-induced Oral Mucositis.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	30591459
Pubmed	In vivo reversal of glutathione deficiency and susceptibility to in vivo dexamethasone-induced apoptosis by N-acetylcysteine and L-2-oxothiazolidine-4-carboxylic acid, but not ascorbic acid, in thymocytes from gamma-glutamyltranspeptidase-deficient knockout mice.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	11795900
Pubmed	Cell membrane expression of cardiac sodium channel Na(v)1.5 is modulated by alpha-actinin-2 interaction.	ACTN4 ACTN1 ACTN2	3.42e-06	5	245	3	19943616
Pubmed	Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene.	GGT1 GGT3P GGT2P	3.42e-06	5	245	3	19760322
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	MCMBP GBF1 CASP14 COPB2 CKAP5 ACTN4 ACTN1 SREK1 ADAR DDB1 EHD4 S100A10 SF3A3 TJP2 HTATSF1 HSPA1L ALDH6A1 UTRN VCP AMPD1 DDX17 PNN LAMC1 CYRIB SEPHS1 FXR1	4.84e-06	1367	245	26	32687490
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	GBF1 PPP2R2D COPB2 WRNIP1 CKAP5 BIRC6 NDUFB7 DDB1 NF1 TMTC3 P3H1 RHBDD3 ALDH1B1 SDHA VCP OTUD4 BZW1	4.96e-06	657	245	17	36180527
Pubmed	The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets.	MYLK ACTN4 ACTN1 ACTN2 AP2B1 SF3A3 TJP2 FXR1 EIF2S1 MPHOSPH6	4.99e-06	225	245	10	25277244
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	ZSWIM8 COPB2 WRNIP1 NEDD1 STAT2 DNAAF3 SEC24D AP2B1 TJP2 EEF2K OSCP1 PIH1D1 TTF2 STRN3 RIOK1 DDX17 SLU7 EIF2S1 CSNK1E OTUD4 GIGYF2 TJP3	5.09e-06	1038	245	22	26673895
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	PPP2R2D BEX5 COPB2 ACTN4 ACTN1 DDB1 GUF1 AP2B1 HSPA1L UTRN VCP CA2 RIC3 RAB25 DDX17 CYRIB SMARCC2 MACF1 BZW1	5.31e-06	807	245	19	30575818
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CKAP5 MPDZ GIT2 DDB1 NF1 SEPTIN3 AP2B1 PLCL1 STRN3 DSCAM ARHGEF12 CYRIB STRIP1 KIF7 FXR1 N4BP2 OTUD4 SMARCC2 GIGYF2 MACF1 PCNT	5.47e-06	963	245	21	28671696
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MCMBP PPP2R2D PPP1R12B COPB2 EXOC3 ACTN4 BIRC6 ADD2 EHD4 PTPRM PTPRZ1 P3H1 MLH1 PIH1D1 UTRN RELCH ZNF280C ESF1 KIF7 KMT2D OTUD4 PCNT	6.01e-06	1049	245	22	27880917
Pubmed	Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion.	ACTN4 ACTN1 ACTN2	6.80e-06	6	245	3	18425115
Pubmed	Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse.	GGT1 GGT3P GGT2P	6.80e-06	6	245	3	8101000
Pubmed	Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage.	ADSL AMPD1 AMPD3	6.80e-06	6	245	3	29079593
Pubmed	Gamma-glutamyl leukotrienase, a novel endothelial membrane protein, is specifically responsible for leukotriene D(4) formation in vivo.	GGT1 GGT3P GGT2P	6.80e-06	6	245	3	12163373
Pubmed	Ablation of Mrds1/Ofcc1 induces hyper-γ-glutamyl transpeptidasemia without abnormal head development and schizophrenia-relevant behaviors in mice.	GGT1 GGT3P GGT2P	6.80e-06	6	245	3	22242126
Pubmed	Four distinct membrane-bound dipeptidase RNAs are differentially expressed and show discordant regulation with gamma-glutamyl transpeptidase.	GGT1 GGT3P GGT2P	6.80e-06	6	245	3	8663190
Pubmed	Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor.	GGT1 GGT3P GGT2P	6.80e-06	6	245	3	14634009
Pubmed	The Alström syndrome protein, ALMS1, interacts with α-actinin and components of the endosome recycling pathway.	ACTN4 ACTN1 ACTN2	6.80e-06	6	245	3	22693585
Pubmed	Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes.	GGT1 GGT3P GGT2P	6.80e-06	6	245	3	8104871
Interaction	KCTD13 interactions	ATP6V0A1 MAP2 PPP1R12B SPTB COPB2 WRNIP1 CKAP5 ACTN4 ACTN1 ACTN2 NDUFB7 DDB1 ADD2 NF1 AP2B1 FGD4 PTPRZ1 SPON1 TJP2 PLCL1 ALDH1B1 HSPA1L UTRN SDHA VCP CA2 STRN3 DDX17 ARHGEF12 CYRIB STRIP1 PPP2R2C FXR1 SUGP2 EIF2S1 VCAN OTUD4 SMARCC2 MACF1 SNTA1	1.87e-07	1394	240	40	int:KCTD13
Interaction	YWHAG interactions	DENND4A MCMBP HIVEP1 GBF1 MAP2 CKAP5 MPDZ ACTN4 GIT2 CDK14 DENND2B PYHIN1 NF1 SIMC1 TJP2 ALDH1B1 PIH1D1 UTRN SDHA VCP DDX17 SASH1 PNN IFI16 DNAH7 KIF7 FXR1 CSNK1E N4BP2 GIGYF2 MACF1 MAST3 HTT DOP1A OTOG	2.04e-06	1248	240	35	int:YWHAG
Interaction	YWHAH interactions	DENND4A MCMBP HIVEP1 GBF1 MAP2 CKAP5 MPDZ BCL2L1 GIT2 DPP8 CDK14 DENND2B PYHIN1 NF1 KCNH2 TJP2 ALDH1B1 UTRN VCP SASH1 PNN DNAH7 KIF7 FXR1 CSNK1E GIGYF2 MACF1 MAST3 HTT DOP1A OTOG PCNT	2.86e-06	1102	240	32	int:YWHAH
Interaction	PYHIN1 interactions	DCAF1 WRNIP1 CKAP5 DDB1 PYHIN1 GPC4 SF3A3 HTATSF1 TTF2 ZNF280C SLU7 BUD13 LAMC1 SUGP2 VCAN GIGYF2	6.67e-06	358	240	16	int:PYHIN1
Interaction	GLDC interactions	PPP2R2D MPDZ ACTN4 ACTN1 ADAR DDB1 TJP2 VCP DDX17 PNN ESF1 FXR1 SUGP2 SMARCC2 GIGYF2	7.66e-06	321	240	15	int:GLDC
Interaction	PFN1 interactions	GIT2 BIRC6 STAT2 NF1 TJP2 EEF2K PIH1D1 FMNL1 SDHA VCP TTF2 STRN3 ARHGEF12 KIF7 N4BP2 MACF1 UGGT2 HTT PCNT	1.21e-05	509	240	19	int:PFN1
Interaction	ACLY interactions	ASXL1 MYLK PPP2R2D CKAP5 DDB1 ADSL ALDH1B1 PIH1D1 SDHA VCP RIOK1 IFI16 PPP2R2C FXR1 HTT	1.27e-05	335	240	15	int:ACLY
Interaction	CEP128 interactions	ZSWIM8 CKAP5 NEDD1 ADSL AP2B1 TJP2 HTATSF1 SDHA TTF2 TANK GPATCH1 KIF7 CSNK1E TXLNG	1.40e-05	297	240	14	int:CEP128
Interaction	BIRC6 interactions	GBF1 COPB2 BIRC6 GREB1L NF1 PRSS45P CARS2 PIH1D1 ALDH6A1 SDHA PNN FSD2 UGGT2	1.88e-05	265	240	13	int:BIRC6
Interaction	SIRT7 interactions	DCAF1 ZSWIM8 COPB2 CKAP5 ACTN4 ACTN1 BIRC6 DDB1 BPTF NF1 AP2B1 TJP2 UTRN SDHA VCP PNN ESF1 FXR1 SUGP2 SMARCC2 GIGYF2 MACF1 PCNT	3.03e-05	744	240	23	int:SIRT7
Interaction	MYH2 interactions	OBSCN ACTN4 ACTN1 ACTN2 UBAC1 AMPD1	3.85e-05	53	240	6	int:MYH2
Interaction	DCAF12 interactions	DCAF1 MCMBP HIVEP1 CASP14 BIRC6 DDB1 DDX17 GPATCH1	4.55e-05	108	240	8	int:DCAF12
Interaction	ZUP1 interactions	ZSWIM8 CASP14 EXOC3 DDB1 NF1 TJP2 HSPA1L UTRN RELCH KIF7	4.66e-05	174	240	10	int:ZUP1
Interaction	CIT interactions	SPTB COPB2 CKAP5 ACTN4 ACTN1 ACTN2 SREK1 ADAR BIRC6 DDB1 NUP54 PYHIN1 S100A10 BPTF AP2B1 SF3A3 TJP2 HSPA1L SDHA AMPD3 DDX17 DSCAM PNN IFI16 PPWD1 TOE1 ESF1 FXR1 DNAH12 SUGP2 EIF2S1 SMARCC2 MACF1 MPHOSPH6 STAG3	5.05e-05	1450	240	35	int:CIT
Interaction	PRSS45P interactions	BIRC6 UBAC1 PRSS45P	5.64e-05	7	240	3	int:PRSS45P
Interaction	SF3A3 interactions	ASXL1 ACTN4 RGS9 ACTN1 SREK1 DDB1 PYHIN1 SF3A3 DDX17 PNN GPATCH1 IFI16 PPWD1 HTT	6.17e-05	340	240	14	int:SF3A3
Interaction	RGS9 interactions	ACTN4 RGS9 ACTN2 SF3A3	6.61e-05	19	240	4	int:RGS9
Interaction	CHMP4C interactions	CASP14 SPTB COPB2 ACTN4 ACTN1 ACTN2 ADAR DDB1 ITIH3 S100A10 HSPA1L VCP DDX17 PNN SLU7 IFI16 CYRIB FXR1 EIF2S1 MACF1 STAG3	7.96e-05	687	240	21	int:CHMP4C
Interaction	SNAI3 interactions	TJP2 STRN3 STRIP1	8.94e-05	8	240	3	int:SNAI3
Interaction	YWHAZ interactions	BDP1 ASXL1 DENND4A HIVEP1 GBF1 PPP2R2D MAP2 CKAP5 DPP8 NEB CDK14 DENND2B NF1 ADSL AP2B1 SIMC1 TJP2 ALDH1B1 PIH1D1 SDHA VCP SASH1 LAMC1 IFI16 CSNK1E OTUD4 GIGYF2 MACF1 MAST3 HTT OTOG PCNT	9.99e-05	1319	240	32	int:YWHAZ
GeneFamily	Actinins	ACTN4 ACTN1 ACTN2	3.36e-06	4	172	3	1112
GeneFamily	CD molecules\|Gamma-glutamyltransferases	GGT1 GGT3P GGT2P	2.26e-04	13	172	3	564
GeneFamily	WD repeat domain containing\|Protein phosphatase 2 regulatory subunits	PPP2R2D STRN3 PPP2R2C	3.54e-04	15	172	3	696
GeneFamily	Dyneins, axonemal	DNAH2 DNAH7 DNAH12	5.22e-04	17	172	3	536
GeneFamily	Aldehyde dehydrogenases	ALDH1B1 ALDH1A3 ALDH6A1	7.33e-04	19	172	3	398
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	PYHIN1 IFI16	8.83e-04	5	172	2	995
GeneFamily	Type 2 receptor serine/threonine kinases	ACVR2A BMPR2	8.83e-04	5	172	2	346
GeneFamily	Adenosine deaminase family	AMPD1 AMPD3	1.32e-03	6	172	2	1302
GeneFamily	PDZ domain containing	MPDZ TJP2 ARHGEF12 SNTA1 MAST3 TJP3	3.36e-03	152	172	6	1220
GeneFamily	EF-hand domain containing\|Diacylglycerol kinases	DGKG DGKK	3.85e-03	10	172	2	1178
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	PRDM2 SUV39H2 KMT2D	4.08e-03	34	172	3	487
GeneFamily	Fibronectin type III domain containing	MYLK OBSCN PTPRM PTPRZ1 DSCAM FSD2	4.32e-03	160	172	6	555
Coexpression	BENPORATH_NANOG_TARGETS	SP2 ASXL1 GBF1 MAN2C1 PCNX3 MPDZ CDK14 ADAR NUP54 EHD4 RPP25 GPC4 MLH1 CARS2 PIH1D1 FEM1A CA2 TTF2 RAB25 DDX17 SASH1 POU4F1 IFI16 KLHL5 FXR1 SUGP2 CSNK1E VCAN PPP1R16B VRTN MRAP2	3.30e-09	988	243	31	M6616
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	ASXL1 GBF1 PPP1R12B CKAP5 BIRC6 BPTF BMPR2 NF1 UTRN CNOT6L MACF1	1.03e-06	180	243	11	M8239
Coexpression	GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN	NREP ADAR STAT2 EHD4 CFLAR RHBDD3 ABCC5 POU4F1 IFI16 KMT2D DOP1A	2.38e-06	196	243	11	M9590
Coexpression	GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	GBF1 MPDZ ACTN4 GIT2 PYHIN1 PTPRM CAMTA1 VCP ARHGEF12 CNOT6L MYO1F	2.62e-06	198	243	11	M6522
Coexpression	BENPORATH_SOX2_TARGETS	SP2 GBF1 MAN2C1 PCNX3 CDK14 ADAR MLH1 PIH1D1 FEM1A CA2 TTF2 RAB25 DDX17 SASH1 IFI16 KLHL5 SUGP2 CSNK1E VCAN VRTN TJP3	5.53e-06	734	243	21	M3835
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	BDP1 DENND4A MCMBP STK17A GIT2 DPP8 ADAR BIRC6 PRDM2 TBC1D20 PYHIN1 S100A10 BPTF NLRC5 UTRN FMNL1 DDX17 TANK PNN PHLDA1 IFI16 ATP8B2 CYRIB KMT2D CNOT6L EPC1 MYO1F PPP1R16B OTUD4 MACF1 BZW1 MAST3	8.84e-06	1492	243	32	M40023
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	BDP1 MAP2 SYTL2 ACVR2A NEB NREP PRDM2 EHD4 SLC9A7 SYT4 CAMTA1 DOCK3 DSCAM CCDC186 ARHGEF12 ABCC5 STRIP1 PPP2R2C CNOT6L CELSR3 SUGP2 N4BP2 VCAN OTUD4 SMARCC2 DOP1A	1.40e-05	1106	243	26	M39071
Coexpression	GSE360_DC_VS_MAC_DN	ZSWIM8 CKAP5 ACVR2A NREP DENND2B S100A10 DLEC1 IFI16 MYO1F C6orf47	1.72e-05	198	243	10	M5173
Coexpression	GSE22886_NAIVE_TCELL_VS_NKCELL_DN	ZSWIM8 PYHIN1 CFLAR CCDC186 ARHGEF12 IFI16 ATP10D GIGYF2 MACF1 HTT	1.72e-05	198	243	10	M4415
Coexpression	GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_DN	MAN2C1 SYT12 SYTL2 NDUFB7 TBC1D20 PTPRM TJP2 RHBDD3 SUV39H2 UGGT2	1.80e-05	199	243	10	M3706
Coexpression	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN	ACP6 ASXL1 DPP8 CLCN1 TTF2 GPATCH1 ZNF254 ESF1 SMARCC2 TXLNG	1.88e-05	200	243	10	M4994
Coexpression	GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN	MAN2C1 SYTL2 TJP2 PLCL1 ATP6V0D2 COL27A1 POLG SH2B1 CSNK1E MYO1F	1.88e-05	200	243	10	M6556
Coexpression	GAVIN_FOXP3_TARGETS_CLUSTER_P3	ATP6V0A1 SYTL2 GGT1 GGT3P ATP6V0D2 ARHGEF12 LAMC1 GGT2P MYO1F	3.61e-05	173	243	9	MM725
Coexpression	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	BCAT2 ACTN2 CLCN1 PTPRM UBAC1 MLH1 TJP2 PLCL1 SDHA CPT1B PLA2G4C	3.65e-05	262	243	11	M2584
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ASXL1 HIVEP1 GBF1 CKAP5 NREP DENND2B BPTF SEC24D PTPRM TJP2 STRN3 DDX17 TANK SASH1 LAMC1 FXR1 OTUD4 GIGYF2 MACF1 MICU2 PCNT	5.35e-05	856	243	21	M4500
Coexpression	JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP	MYLK SYTL2 ACTN4 BCL2L1 ACTN1 S100A10 SEPTIN3 SLC9A7 ALDH1A3 CA2 SASH1 MACF1 UGGT2	6.40e-05	382	243	13	M38972
Coexpression	GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP	STK17A CDK14 PRDM2 ADD2 SPON1 LAMC1 PPP1R16B ATP2A3 STAG3	8.43e-05	193	243	9	M4961
Coexpression	LOPEZ_MBD_TARGETS	MAGEA8 CYP2A6 POGLUT3 SYT12 CYP8B1 PPP1R12B COPB2 ACTN4 ACTN1 ACTN2 NDUFB7 DDB1 ITIH3 PRDM2 S100A10 ADSL UBAC1 HSPA1L ABCC5 SH2B1 EIF2S1 SMARCC2	8.62e-05	953	243	22	M4120
Coexpression	AKL_HTLV1_INFECTION_UP	NREP ADD2 S100A10 AP2B1	1.07e-04	27	243	4	M7705
Coexpression	ENK_UV_RESPONSE_EPIDERMIS_UP	ACP6 MYLK BCL2L1 ACTN1 ADSL TJP2 ALDH1A3 CA2 AMPD3 MPHOSPH6 HTT	1.09e-04	296	243	11	M19848
Coexpression	GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP	ACTN1 ADAR CFLAR TJP2 NLRC5 AMPD3 COL27A1 ABCC5 CSNK1E	1.11e-04	200	243	9	M8657
Coexpression	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN	POGLUT3 NEB EHD4 S100A10 BMPR2 TJP2 ATP6V0D2 PHLDA1 ATP10D	1.11e-04	200	243	9	M7958
Coexpression	GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP	PCNX3 GIT2 CFLAR NF1 PTPRM FMNL1 ARHGEF12 MYO1F ATP2A3	1.11e-04	200	243	9	M6524
Coexpression	MASSARWEH_TAMOXIFEN_RESISTANCE_UP	POGLUT3 DENND4A MYLK ACVR2A GREB1L TMTC3 TJP2 ALDH1A3 UTRN RELCH SASH1 ABCC5 CSNK1E UGGT2 BZW1 ATP2A3	1.20e-04	583	243	16	M17454
Coexpression	GRUETZMANN_PANCREATIC_CANCER_UP	MYLK SRI NREP NDUFB7 CFLAR S100A10 BPTF AMPD3 TANK VCAN MPHOSPH6 BZW1	1.44e-04	359	243	12	M15193
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	STK17A SYTL2 CKAP5 BCL2L1 S100A10 HTATSF1 TANK PNN IFI16 PPWD1 ESF1 KLHL5 FXR1 CELSR3 EIF2S1 VCAN UGGT2 BZW1	1.49e-04	721	243	18	M10237
Coexpression	ESC_V6.5_UP_EARLY.V1_UP	SYTL2 ITIH3 SIMC1 SASH1 SUV39H2 ATP8B2 CELSR3 MAST3	1.67e-04	166	243	8	M2770
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 SYTL2 SREK1 PYHIN1 BPTF NLRC5 UTRN RELCH DDX17 PNN SUGP2 MACF1	1.21e-09	199	245	12	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 SREK1 ADAR BIRC6 STAT2 PRDM2 BPTF UTRN DDX17 PNN IFI16 MACF1	1.29e-09	200	245	12	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MPDZ NREP BIRC6 BPTF BMPR2 PTPRM UTRN ARHGEF12 IFI16 MACF1 PCNT	1.57e-08	200	245	11	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	MPDZ NREP EHD4 BPTF BMPR2 PTPRM ARHGEF12 IFI16 KLHL5 MACF1	1.73e-07	200	245	10	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	15-Trachea-Epithelial-Neuroendocrine\|Trachea / Age, Tissue, Lineage and Cell class	PCSK2 BEX5 NEB KCNH6 KCNH2 SYT4 HS3ST4 RIC3 CELSR3	1.18e-06	191	245	9	76311fa5f3ae9bb27cf04387a8c92300f2888c28
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	MYLK PPP1R12B SYTL2 DGKG BCAT2 ACTN4 ACTN1 ITIH3 MRAP2	1.47e-06	196	245	9	541b1fcf509e362f6f48720046cb5378aaf7c591
ToppCell	facs-Trachea-3m\|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COPB2 ACTN4 NREP SEC24D VCP STRN3 SASH1 ARHGEF12 BZW1	1.53e-06	197	245	9	e77016d64b1cac9825fec7cfe5071f1567401187
ToppCell	facs-Trachea-nan-3m\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPB2 ACTN4 NREP SEC24D VCP STRN3 SASH1 ARHGEF12 BZW1	1.53e-06	197	245	9	0353d925ee4b7aefc2c51b5fab873f465cdf9ebc
ToppCell	COVID-19-kidney-T-cells-1\|kidney / Disease (COVID-19 only), tissue and cell type	STK17A ELMO1 PYHIN1 NLRC5 FMNL1 IFI16 CNOT6L MYO1F PPP1R16B	1.53e-06	197	245	9	9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SPTB DGKG RGS9 RPP25 PTPRM SPON1 UTRN SLC27A2	1.60e-06	147	245	8	50e86860a94be103092c40e39a172eac92372f0d
ToppCell	normal_Lung-Fibroblasts-Smooth_muscle_cells\|Fibroblasts / Location, Cell class and cell subclass	MYLK PPP1R12B SPTB SYTL2 DGKG ACTN4 ACTN1 ITIH3 GPC4	1.66e-06	199	245	9	d65847ceb68a560798df3f73e6f838e7c3e38a1c
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	STK17A SYTL2 PYHIN1 NLRC5 ATP8B2 CNOT6L PPP1R16B MACF1 ATP2A3	1.66e-06	199	245	9	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYLK ADAR BMPR2 PTPRM SASH1 ARHGEF12 IFI16 PLA2G4C MACF1	1.73e-06	200	245	9	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	SREK1 ADAR PRDM2 BPTF UTRN PNN EPC1 MACF1 BZW1	1.73e-06	200	245	9	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Children_(3_yrs)-Immune-mast_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CDK15 SPTB SYTL2 KCNH2 PLCL1 ALDH1B1 SLC27A2 GCSAML	1.96e-06	151	245	8	bbf735c6433c3fc2feedb24ed6f48c51d545fb60
ToppCell	356C-Myeloid-Mast_cell-\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CDK15 SPTB SYTL2 KCNH2 SLC27A2 RIC3 DNAH2 GCSAML	3.63e-06	164	245	8	f7288ec4daf494dae770ea6c58bead27660ccae1
ToppCell	356C-Myeloid-Mast_cell\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CDK15 SPTB SYTL2 KCNH2 SLC27A2 RIC3 DNAH2 GCSAML	3.63e-06	164	245	8	b3192c443f4848e6a8afdb89c155f9ec42a154b0
ToppCell	RV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	PPP1R12B OBSCN ACTN2 PTPRM PLCL1 HSPA1L DOCK3	5.13e-06	122	245	7	1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTB OBSCN ACTN2 NEB CLCN1 KCNH2 FSD2 CPT1B	5.15e-06	172	245	8	ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTB OBSCN ACTN2 NEB CLCN1 KCNH2 FSD2 CPT1B	5.15e-06	172	245	8	bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nr2f2_Necab1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SPTB RPP25 SPON1 FGF8 SLC27A2 SASH1 MRAP2	5.71e-06	124	245	7	298ff8bd8f0459f44ce8a8aea889c6f1cf84ac5f
ToppCell	Mild/Remission-B_intermediate-10\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DGKG NEB PYHIN1 BMPR2 FGD4 PLCL1 PPP1R16B MACF1	8.12e-06	183	245	8	278064c9f0582463b83bf156d34e77f60187613b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	HIVEP1 SYTL2 ACTN1 DENND2B DOCK3 SCMH1 VCAN MACF1	8.45e-06	184	245	8	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PPP1R12B SPTB OBSCN DGKG ACTN2 GREB1L PLCL1 DOCK3	8.79e-06	185	245	8	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	Fibroblast-A\|World / shred on cell class and cell subclass (v4)	POGLUT3 MYLK NREP SPON1 PHLDA1 VCAN MACF1 SLC7A10	9.89e-06	188	245	8	6740bed5fb8f45b6eea17041894b804214c2a4ae
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	PPP1R12B OBSCN DGKG ACTN2 GREB1L PLCL1 DOCK3 FSD2	1.03e-05	189	245	8	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DCHS2 OBSCN RGS9 DENND2B BMPR2 SASH1 PLA2G4C CABCOCO1	1.07e-05	190	245	8	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK BPTF BMPR2 TJP2 UTRN ARHGEF12 KLHL5 MACF1	1.07e-05	190	245	8	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK SYTL2 ACTN1 NREP DENND2B S100A10 GPC4 VCAN	1.11e-05	191	245	8	89d03c4133dda852a3713c0902a7d67941cf5b21
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	PPP1R12B OBSCN DGKG ACTN2 GREB1L PTPRM PLCL1 FSD2	1.11e-05	191	245	8	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	COVID-19-lung-CD8+_T_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	STK17A SYTL2 PYHIN1 FMNL1 CNOT6L MYO1F PPP1R16B ATP2A3	1.11e-05	191	245	8	543f8ae07cc2e6950c888115a5ca9445e3c0f618
ToppCell	normal_Lung-Epithelial_cells-Ciliated\|normal_Lung / Location, Cell class and cell subclass	IQCD DNAAF3 DLEC1 OSCP1 DNAH2 DNAH7 DNAH12 CABCOCO1	1.15e-05	192	245	8	097a13121820ab4e5cd2365600efccf5ea4ce8c3
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	BDP1 ASXL1 HIVEP1 SREK1 BPTF HS3ST4 UTRN VCAN	1.15e-05	192	245	8	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK NREP SPON1 PHLDA1 LAMC1 VCAN MACF1 SLC7A10	1.15e-05	192	245	8	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	PPP1R12B OBSCN DGKG ACTN2 GREB1L PLCL1 DOCK3 FSD2	1.15e-05	192	245	8	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	CDK14 ABCA10 SEC24D SPON1 SASH1 LAMC1 VCAN UGGT2	1.15e-05	192	245	8	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK NREP SPON1 PHLDA1 LAMC1 VCAN MACF1 SLC7A10	1.15e-05	192	245	8	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	multiciliated\|World / shred by cell class for turbinate	IQCD DNAAF3 DLEC1 OSCP1 DNAH2 DNAH7 DNAH12 CABCOCO1	1.15e-05	192	245	8	0f89ea0deb651ca11531c51ee94e0233608d22ea
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND4A CDK14 BIRC6 ELMO1 PTPRM FGD4 HS3ST4 UTRN	1.20e-05	193	245	8	779276e775cb2492e8dd36436295a536084a6415
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYLK PPP1R12B DGKG ACTN4 ACTN1 ITIH3 GPC4 MRAP2	1.20e-05	193	245	8	5260ac95a15cc43a19909badad0c7e3854da920d
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	BDP1 ASXL1 HIVEP1 SREK1 BPTF HS3ST4 UTRN VCAN	1.20e-05	193	245	8	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYTL2 TMTC3 UTRN RELCH DDX17 GCSAML SUGP2 MACF1	1.20e-05	193	245	8	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYLK PPP1R12B DGKG ACTN4 ACTN1 ITIH3 GPC4 MRAP2	1.20e-05	193	245	8	5ec917931b438dd0e7fb03eb6af459d3ef6b84ba
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PCSK2 BEX5 KCNH6 FGD4 SYT4 RIC3 DOCK3 DSCAM	1.24e-05	194	245	8	b30379f8dc41c86c746af9930541fbb4819d8fa0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK MAP2 PPP1R12B DGKG ACTN1 DENND2B UTRN VCAN	1.24e-05	194	245	8	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POGLUT3 MYLK NREP SPON1 PHLDA1 VCAN MACF1 SLC7A10	1.29e-05	195	245	8	cbe518b465b4ef32797ae6b608219207c08493df
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK ACTN1 NREP SEC24D P3H1 SPON1 COL27A1 VCAN	1.29e-05	195	245	8	18b01ab63ee1deae3cf29669d66fff9ca4efc5c4
ToppCell	P03-Mesenchymal\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYLK NREP SPON1 PHLDA1 COL27A1 VCAN MACF1 SLC7A10	1.29e-05	195	245	8	6180309c6ae278b996fd98c57461cbc129c028ba
ToppCell	(1)_T_cells-(1)_T_CD4_naive\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ACTN1 ADD2 BPTF RIC3 DDX17 PNN ATP8B2 N4BP2	1.29e-05	195	245	8	d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCell	cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IQCD DNAAF3 DLEC1 OSCP1 DNAH2 DNAH7 DNAH12 CABCOCO1	1.29e-05	195	245	8	d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e
ToppCell	PND03-Mesenchymal-Mesenchymal_structural\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POGLUT3 MYLK NREP SPON1 PHLDA1 VCAN MACF1 SLC7A10	1.29e-05	195	245	8	136b06b0931a69b1241101f68c01c44c70365fd9
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	MAP2 BCL2L1 ELMO1 BMPR2 PTPRM UTRN KLHL5 PPP1R16B	1.29e-05	195	245	8	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	Fibroblasts-Pericytes\|Fibroblasts / lung cells shred on cell class, cell subclass, sample id	MYLK PPP1R12B SYTL2 DGKG BCAT2 ACTN4 ACTN1 MOB2	1.29e-05	195	245	8	c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1
ToppCell	11.5-Distal-Epithelial-Neuroendocrine\|Distal / Age, Tissue, Lineage and Cell class	PCSK2 BEX5 KCNH6 SYT4 RIC3 RAB25 DSCAM ATP2A3	1.29e-05	195	245	8	eda6ebe52c48bd6a9044886e75f584f46c2556e7
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POGLUT3 MYLK NREP SPON1 PHLDA1 VCAN MACF1 SLC7A10	1.34e-05	196	245	8	14246f00c90741a5f8683f377e22e3a7c99661b9
ToppCell	Pericytes\|World / shred by cell class for parenchyma	MYLK PPP1R12B SYTL2 DGKG ACTN1 ITIH3 ALDH1B1 MRAP2	1.34e-05	196	245	8	8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POGLUT3 MYLK NREP SPON1 PHLDA1 VCAN MACF1 SLC7A10	1.34e-05	196	245	8	2a885eed52f9b002c7995e11e450c7e8d7ae69e6
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37\|World / Primary Cells by Cluster	MAP2 BEX5 NREP S100A10 HS3ST4 RIC3 KLHL5 PPP2R2C	1.39e-05	197	245	8	00d756bc0231e1b3b88430214338c1059cb11106
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK SYTL2 ACTN1 NREP DENND2B KCNH2 GPC4 VCAN	1.39e-05	197	245	8	398a66c06df63567b176ab2cc85e27837e94d0d9
ToppCell	MatrixFB\|World / shred on cell class and cell subclass (v4)	POGLUT3 MYLK NREP SPON1 PHLDA1 COL27A1 VCAN MACF1	1.39e-05	197	245	8	e325de44e32021a36fffb7b7e88167b46bb051c7
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK PPP1R12B SYTL2 ACTN1 NREP DENND2B KCNH2 GPC4	1.39e-05	197	245	8	94a7270ea6d4b586f58875c9e4071ce0f683ef7e
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	MYLK MAP2 PPP1R12B SYTL2 DGKG ACTN4 ACTN2 ITIH3	1.44e-05	198	245	8	89986c7756541df364df516329d10775ba0e78a4
ToppCell	wk_20-22-Epithelial-Proximal_epithelial\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	DNAAF3 DLEC1 OSCP1 DNAH2 DNAH7 DNAH12 CABCOCO1 TJP3	1.44e-05	198	245	8	16c54b884500066ade05a406915f9569ca8abdfc
ToppCell	Mild-CD8+_T_activated\|Mild / Disease group and Cell class	ADAR STAT2 S100A10 OTOF NLRC5 TANK IFI16 DOP1A	1.44e-05	198	245	8	ceac1b51bacfd0dd7fe7c6a666f7927055e1f380
ToppCell	medial-Epithelial-Ciliated\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IQCD DNAAF3 DLEC1 DNAH2 DNAH7 DNAH12 CABCOCO1 TJP3	1.49e-05	199	245	8	a2daa42b100c422dc8c04fb7d2ebf54293eef574
ToppCell	facs-Trachea-nan-3m-Mesenchymal-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POGLUT3 COPB2 NREP SEC24D P3H1 GPC4 SASH1 VCAN	1.49e-05	199	245	8	1ae244b563f85c1ee8d22698f478c842a4d9c7f5
ToppCell	medial-Epithelial-Ciliated-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IQCD DNAAF3 DLEC1 DNAH2 DNAH7 DNAH12 CABCOCO1 TJP3	1.49e-05	199	245	8	526002f16bbf61cf086278d45a401cc0b0b757a8
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	MYLK PPP1R12B BPTF GPC4 CCDC186 ARHGEF12 IFI16 KLHL5	1.49e-05	199	245	8	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	distal-Epithelial-Ciliated\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IQCD DNAAF3 DLEC1 OSCP1 DNAH2 DNAH7 DNAH12 CABCOCO1	1.49e-05	199	245	8	18ca031cfe702afb9bf94e03c0f3680c38e7599e
ToppCell	medial-2-Epithelial-Ciliated\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IQCD DNAAF3 DLEC1 DNAH2 DNAH7 DNAH12 CABCOCO1 TJP3	1.49e-05	199	245	8	c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	PCSK2 MAP2 NREP BPTF AP2B1 RIC3 CCDC186 ARHGEF12	1.49e-05	199	245	8	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	PCSK2 MAP2 NREP BPTF AP2B1 RIC3 CCDC186 ARHGEF12	1.49e-05	199	245	8	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	distal-2-Epithelial-Ciliated\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IQCD DNAAF3 DLEC1 OSCP1 DNAH2 DNAH7 DNAH12 CABCOCO1	1.49e-05	199	245	8	97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60
ToppCell	facs-Trachea-nan-3m-Mesenchymal\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POGLUT3 COPB2 NREP SEC24D P3H1 GPC4 SASH1 VCAN	1.49e-05	199	245	8	67f78c070c56e44fba36542041bf7fa1c291807c
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTB NEB CLCN1 AMPD1 FSD2 STAG3 PCNT	1.52e-05	144	245	7	f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCell	343B-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYLK PPP1R12B ACTN4 ACTN1 ITIH3 MOB2 CAMTA1 MRAP2	1.55e-05	200	245	8	4fb6fd703aca9a992924245105ad99163146a415
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ADAR BMPR2 NF1 PTPRM ARHGEF12 IFI16 PLA2G4C MACF1	1.55e-05	200	245	8	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_only / Treatment groups by lineage, cell group, cell type	NREP MOB2 BMPR2 PTPRM SASH1 ARHGEF12 IFI16 PLA2G4C	1.55e-05	200	245	8	b1fadb2b5e37e0f51e079d8409c2647eef68dc3b
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	STK17A ADAR STAT2 BPTF UTRN DDX17 IFI16 MACF1	1.55e-05	200	245	8	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	STK17A SYTL2 PYHIN1 NLRC5 IFI16 CNOT6L MYO1F PPP1R16B	1.55e-05	200	245	8	02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	NREP BMPR2 PTPRM SASH1 ARHGEF12 IFI16 PLA2G4C MACF1	1.55e-05	200	245	8	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	NREP BMPR2 PTPRM DDX17 SASH1 ARHGEF12 IFI16 MACF1	1.55e-05	200	245	8	eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	NREP BMPR2 PTPRM SASH1 ARHGEF12 IFI16 PLA2G4C MACF1	1.55e-05	200	245	8	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NREP BPTF BMPR2 PTPRM UTRN ARHGEF12 IFI16 MACF1	1.55e-05	200	245	8	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	SYTL2 ADAR PYHIN1 UTRN ARHGEF12 IFI16 DGKK MACF1	1.55e-05	200	245	8	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	343B-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYLK PPP1R12B ACTN4 ACTN1 ITIH3 MOB2 CAMTA1 MRAP2	1.55e-05	200	245	8	b50de1f8c8f598e281951e4587f2d96c11aac836
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RGS9 SPON1 ECEL1 SLC27A2 FSD2 ADAM32	1.60e-05	97	245	6	f3c3fb260954f594a9ab8e1ac9a01115767cbc7a
ToppCell	356C-Myeloid-Mast_cell\|356C / Donor, Lineage, Cell class and subclass (all cells)	CDK15 SPTB KCNH2 SLC27A2 DNAH2 GCSAML PJVK	1.81e-05	148	245	7	1668d8a9e680da335362744f36b05446c499347e
ToppCell	356C-Myeloid-Mast_cell-\|356C / Donor, Lineage, Cell class and subclass (all cells)	CDK15 SPTB KCNH2 SLC27A2 DNAH2 GCSAML PJVK	1.81e-05	148	245	7	18511ba10765eda937c5a710626361f7e6b9b321
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PYHIN1 PTPRM DLEC1 CPT1B DNAH12 CELSR3 C6orf47	1.98e-05	150	245	7	53de595376a9fc92491dfd58ff25938b0bf79903
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PYHIN1 PTPRM DLEC1 CPT1B DNAH12 CELSR3 C6orf47	1.98e-05	150	245	7	e4b40b3243ed26d0c46bf196ac06e148834e7ed2
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|Heart / Disease (COVID-19 only), tissue and cell type	SPTB NEB CLCN1 UBAC1 AMPD1 STAG3 PCNT	2.44e-05	155	245	7	d7e26696fd9c0a759524f331243db43059b33ed9
ToppCell	Adult-Immune-mast_cell-D122\|Adult / Lineage, Cell type, age group and donor	CDK15 CYP8B1 SPTB SYTL2 PLCL1 SLC27A2 GCSAML	2.44e-05	155	245	7	7c9de0591d1bf756b8e268b278bbe10bd5415dcd
ToppCell	10x5'-blood-Lymphocytic_T_CD4-Trm_Th1/Th17\|blood / Manually curated celltypes from each tissue	BEX5 PTPRM RHBDD3 ALDH1B1 FEM1A PHLDA1 GPATCH1	2.65e-05	157	245	7	c99cb26d831c25038f2aa1b1c0f7ba52facb2e7a
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SPTB DGKG RGS9 RPP25 PTPRM UTRN SLC27A2	3.12e-05	161	245	7	dccb61d5e17a8f1c6d1fc146ee389f567659a0f0
ToppCell	Adult-Immune-mast_cell\|Adult / Lineage, Cell type, age group and donor	CDK15 CYP8B1 SPTB SYTL2 SLC27A2 GCSAML ATP2A3	3.12e-05	161	245	7	44f5c0256b3ce264a6c7b62740f32dcd45ee052d
ToppCell	Control-B_intermediate-10\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DGKG NEB CDK14 PYHIN1 FGD4 PLCL1 MRAP2	3.24e-05	162	245	7	aa80452b972bb8ad3670ffaba4ce26fadb33b185
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	ACTN2 ACVR2A UTRN DDX17 ATP8B2 CNOT6L MACF1	3.24e-05	162	245	7	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	control-Epithelial-Ionocyte\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PPP1R12B NREP SIMC1 PLCL1 ATP6V0D2 PHLDA1 ATP2A3	3.65e-05	165	245	7	5cfba9a46bd8ceeca74a6493057b4d38af6b06fe
ToppCell	PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PCSK2 ADD2 FGD4 PTPRZ1 SLC9A7 ALDH1A3 HS3ST4	4.25e-05	169	245	7	d9c3b22f62b882b8a2ea6fd9cf7afbe6d1775745
Drug	Ethamivan [304-84-7]; Down 200; 18uM; PC3; HT_HG-U133A	MCMBP MYLK SRI MPDZ GIT2 CFLAR HTATSF1 ARHGEF12 IFI16 CYRIB SMARCC2 MAST3 DOP1A	1.72e-07	194	242	13	7260_DN
Drug	PHA-00846566E [724718-26-7]; Up 200; 10uM; PC3; HT_HG-U133A	MYLK BCL2L1 GIT2 CFLAR ALDH6A1 SLC27A2 PHLDA1 ARHGEF12 IFI16 CYRIB SNTA1 HTT	1.21e-06	194	242	12	7086_UP
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; PC3; HT_HG-U133A	PPP2R2D SRI GIT2 BMPR2 GPC4 UTRN AMPD3 POLG CPT1B SUGP2 CSNK1E MAST3	1.42e-06	197	242	12	2067_DN
Drug	Nifedipine [21829-25-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ATP6V0A1 ACTN2 PRDM2 ADD2 CFLAR RHBDD3 UTRN TANK PHLDA1 ATP8B2 STAG3 SNTA1	1.66e-06	200	242	12	1692_UP
Drug	2',3'-Dideoxyadenylosuccinate	ADSL AMPD1 AMPD3	4.71e-06	4	242	3	CID000126574
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	STAT2 PRDM2 BMPR2 NF1 AP2B1 RHBDD3 ALDH6A1 UTRN AMPD3 DDX17 CCDC186	6.06e-06	189	242	11	3788_DN
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	MCMBP NEB PRDM2 ALDH1B1 STRN3 DDX17 IFI16 SUV39H2 ATP8B2 CSNK1E TJP3	7.77e-06	194	242	11	4320_DN
Drug	Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; PC3; HT_HG-U133A	SYTL2 BCL2L1 PRDM2 CFLAR AP2B1 ALDH6A1 DDX17 POLG ZNF254 IFI16 ATP10D	7.77e-06	194	242	11	2087_DN
Drug	Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A	SYT12 RTEL1 PYHIN1 CFLAR STRN3 AMPD3 DDX17 CYRIB PLA2G4C STAG3 SNTA1	8.99e-06	197	242	11	2260_DN
Drug	Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A	SYT12 RTEL1 BCL2L1 GIT2 CFLAR P3H1 RHBDD3 POLG SH2B1 CYRIB SUGP2	8.99e-06	197	242	11	1508_DN
Drug	Mephenytoin [50-12-4]; Up 200; 18.4uM; MCF7; HT_HG-U133A	DCAF1 RTEL1 CFLAR NF1 UTRN AMPD3 DDX17 PHLDA1 ATP8B2 ATP10D SUGP2	9.43e-06	198	242	11	6275_UP
Drug	(S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A	GBF1 GIT2 CFLAR RHBDD3 SASH1 PHLDA1 CCDC186 SUV39H2 CELSR3 SUGP2 TJP3	9.43e-06	198	242	11	5325_DN
Drug	Vinpocetine [42971-09-5]; Down 200; 11.4uM; HL60; HG-U133A	ACTN1 CFLAR GUF1 SEC24D AMPD3 TANK PHLDA1 ARHGEF12 PPP1R16B MACF1 MAST3	9.89e-06	199	242	11	1557_DN
Drug	Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; HL60; HG-U133A	RTEL1 SPTB SRI ACTN1 CDK14 FMNL1 SASH1 FPGS SH2B1 PPP1R16B ATP2A3	9.89e-06	199	242	11	1582_UP
Drug	Dibucaine [85-79-0]; Up 200; 11.6uM; PC3; HT_HG-U133A	SYT12 ACTN2 PYHIN1 SPON1 RHBDD3 ALDH1B1 DSCAM DNAH2 CLCA2 PPP1R16B VRTN	9.89e-06	199	242	11	4068_UP
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; PC3; HT_HG-U133A	SYTL2 ALDH6A1 SASH1 FPGS POLG ATP8B2 CYRIB SUGP2 CSNK1E SNTA1 HTT	9.89e-06	199	242	11	7279_DN
Drug	Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A	MAN2C1 GIT2 CFLAR SEC24D BMPR2 ALDH1B1 ALDH6A1 SLC27A2 CLCA2 CA5B SNTA1	1.04e-05	200	242	11	7156_UP
Drug	CBVMP	AMPD1 AMPD3 POLG	1.17e-05	5	242	3	CID000469585
Drug	NSC623156	AMPD1 AMPD3 POLG	2.32e-05	6	242	3	CID000360780
Drug	Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; PC3; HT_HG-U133A	ATP6V0A1 WRNIP1 SEC24D CLCN1 AP2B1 KCNH2 ALDH1B1 IFI16 KCTD14 TJP3	2.77e-05	183	242	10	3704_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	HIVEP1 SYTL2 RPP25 GUF1 SLC27A2 TTF2 DDX17 PHLDA1 SH2B1 TJP3	3.65e-05	189	242	10	1006_DN
Drug	hydroxyl radicals	CLPP ACP6 CYP2A6 CYP2A13 ATP6V0A1 CYP8B1 ADAR GGT1 DHDH PTPRM PTPRZ1 PLCL1 ATP6V0D2 ALDH1B1 ALDH1A3 ALDH6A1 SDHA CA2 SLC27A2 AMPD1 AMPD3 SI ATP8B2 ATP10D SEPHS1 PPP2R2C ACAD8 PLA2G4C TPH2 CA5B ATP2A3	3.97e-05	1341	242	31	CID000000961
Drug	Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A	CDK14 PRDM2 CFLAR GUF1 RHBDD3 ARHGEF12 VCAN CA5B TXLNG DOP1A	4.18e-05	192	242	10	7104_DN
Drug	Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	MAN2C1 RTEL1 CFLAR RHBDD3 ALDH1B1 SASH1 ARHGEF12 PLA2G4C ATP2A3 SNTA1	4.36e-05	193	242	10	5024_DN
Drug	Cefoperazone dihydrate; Down 200; 5.8uM; MCF7; HT_HG-U133A	ZSWIM8 ATP6V0A1 RTEL1 SRI CFLAR NF1 UTRN CPT1B CYRIB CSNK1E	4.76e-05	195	242	10	5424_DN
Drug	Zomepirac sodium salt [64092-48-4]; Up 200; 12.8uM; MCF7; HT_HG-U133A	ATP6V0A1 SYT12 RTEL1 SRI GIT2 CFLAR SEC24D POLG SH2B1 MAST3	4.76e-05	195	242	10	3454_UP
Drug	Doxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A	BCL2L1 NREP RPP25 CFLAR AP2B1 P3H1 ALDH1B1 ALDH6A1 PHLDA1 MYO1F	4.76e-05	195	242	10	4235_DN
Drug	Capsaicin [404-86-4]; Down 200; 13uM; HL60; HT_HG-U133A	MCMBP BCL2L1 NEB PRDM2 CFLAR AP2B1 STRN3 PHLDA1 CSNK1E TJP3	4.76e-05	195	242	10	3034_DN
Drug	Droperidol [548-73-2]; Down 200; 10.6uM; HL60; HT_HG-U133A	DCAF1 ACTN1 RPP25 SASH1 FPGS POLG SH2B1 SUGP2 PPP1R16B SMARCC2	4.76e-05	195	242	10	1290_DN
Drug	Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A	CFLAR SEC24D KCNH2 ALDH1B1 AMPD3 SASH1 POLG CELSR3 ATP2A3 MAST3	4.97e-05	196	242	10	3536_DN
Drug	Primidone [125-33-7]; Up 200; 18.4uM; MCF7; HT_HG-U133A	RTEL1 PPP1R12B CFLAR NF1 UTRN DSCAM POU4F1 ATP8B2 PLA2G4C ATP2A3	4.97e-05	196	242	10	5323_UP
Drug	Nifurtimox [23256-30-6]; Up 200; 14uM; MCF7; HT_HG-U133A	SRI GIT2 DENND2B PRDM2 SEC24D UTRN SASH1 CCDC186 POLG SH2B1	4.97e-05	196	242	10	7328_UP
Drug	(-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A	ASXL1 GBF1 NF1 CARS2 STRN3 PHLDA1 UGGT2 ATP2A3 HTT DOP1A	4.97e-05	196	242	10	7027_DN
Drug	Kawain [500-64-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A	GIT2 PRDM2 CFLAR ALDH1B1 STRN3 AMPD3 CCDC186 BCO1 PLA2G4C MAST3	4.97e-05	196	242	10	4693_UP
Drug	Colistin sulfate [1264-72-8]; Up 200; 3uM; HL60; HT_HG-U133A	RTEL1 PPP1R12B RHBDD3 PLCL1 DSCAM CSNK1E PPP1R16B CA5B ATP2A3 DOP1A	4.97e-05	196	242	10	2491_UP
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	MAP2 ACTN2 DENND2B STAT2 NF1 AMPD3 ATP8B2 BCO1 PLA2G4C MYO1F	5.19e-05	197	242	10	3886_DN
Drug	Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; MCF7; HT_HG-U133A	RTEL1 SRI CFLAR SEC24D KCNH2 STRN3 CCDC186 ARHGEF12 PLA2G4C ATP2A3	5.19e-05	197	242	10	3467_UP
Drug	Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; HL60; HT_HG-U133A	ACP6 ATP6V0A1 STK17A DGKG PHLDA1 CCDC186 POLG SUGP2 PPP1R16B DOP1A	5.19e-05	197	242	10	2972_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	RTEL1 STK17A CFLAR UTRN SH2B1 MYO1F OTUD4 ATP2A3 MAST3 TJP3	5.19e-05	197	242	10	5605_DN
Drug	Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A	ZSWIM8 GBF1 MAN2C1 RTEL1 NEB CFLAR KCNH2 UTRN CYRIB CSNK1E	5.19e-05	197	242	10	7412_UP
Drug	Proxyphylline [603-00-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A	ATP6V0A1 SYT12 RTEL1 GIT2 CFLAR NF1 GPC4 ATP8B2 SH2B1 TJP3	5.19e-05	197	242	10	5993_DN
Drug	Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A	DENND4A RTEL1 SEC24D GPC4 RHBDD3 ALDH1B1 STRN3 DDX17 PHLDA1 SUGP2	5.19e-05	197	242	10	1518_DN
Drug	Isoconazole [27523-40-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ATP6V0A1 RTEL1 PRDM2 RHBDD3 DDX17 POU4F1 CYRIB PLA2G4C ATP2A3 STAG3	5.19e-05	197	242	10	2218_DN
Drug	Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A	MCMBP RTEL1 GIT2 ACVR2A CFLAR ZNF254 SUGP2 CSNK1E SMARCC2 STAG3	5.19e-05	197	242	10	7476_DN
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; HL60; HG-U133A	NUP54 SEC24D TJP2 TTF2 TANK IFI16 CYRIB SCMH1 MACF1 DOP1A	5.19e-05	197	242	10	1395_DN
Drug	Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A	STK17A PPP1R12B GIT2 NEB DENND2B SEC24D NF1 STRN3 ARHGEF12 MYO1F	5.41e-05	198	242	10	5413_DN
Drug	Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A	DENND4A SPTB SYTL2 GREB1L NF1 ALDH1B1 STRN3 AMPD3 ZNF254 CA5B	5.41e-05	198	242	10	7282_UP
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; PC3; HT_HG-U133A	RTEL1 PPP1R12B BCL2L1 RHBDD3 UTRN DDX17 IFI16 SMARCC2 STAG3 SNTA1	5.41e-05	198	242	10	6349_DN
Drug	estradiol, USP; Down 200; 0.1uM; PC3; HT_HG-U133A	DCAF1 ATP6V0A1 STK17A MPDZ GREB1L SLC9A7 ALDH6A1 SH2B1 CA5B TJP3	5.41e-05	198	242	10	4432_DN
Drug	Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; PC3; HT_HG-U133A	DENND4A GREB1L ALDH1B1 AMPD3 CPT1B CELSR3 CLCA2 MYO1F KCTD14 TJP3	5.41e-05	198	242	10	5763_UP
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	SPTB STAT2 PRDM2 SPON1 HTATSF1 UTRN SLC27A2 CYRIB VCAN DOP1A	5.65e-05	199	242	10	4316_DN
Drug	Harpagoside [19210-12-9]; Up 200; 8uM; MCF7; HT_HG-U133A	DENND4A ATP6V0A1 SRI MPDZ PRDM2 KCNH2 ALDH1B1 AMPD3 SMARCC2 ATP2A3	5.65e-05	199	242	10	7355_UP
Drug	Bemegride [64-65-3]; Up 200; 25.8uM; PC3; HT_HG-U133A	ATP6V0A1 MAP2 STAT2 CFLAR KCNH6 SLC9A7 DOCK3 SH2B1 CLCA2 TJP3	5.65e-05	199	242	10	6668_UP
Drug	propargyl ether	CYP2A6 CYP2A13	1.13e-04	2	242	2	ctd:C531209
Drug	N-(1-(2,3-dimethoxyphenyl)-4-methyl-3-penten-1-yl)-1-(5-bromofurfuryl)-1-piperidyl-4-amine	KCNH6 KCNH2	1.13e-04	2	242	2	ctd:C531033
Drug	Hempa	CYP2A6 CYP2A13	1.13e-04	2	242	2	ctd:D006492
Drug	nicotine imine	CYP2A6 CYP2A13	1.13e-04	2	242	2	ctd:C034629
Drug	alpha-nicotyrine	CYP2A6 CYP2A13	1.13e-04	2	242	2	ctd:C008615
Drug	N-nitrosoguvacoline	CYP2A6 CYP2A13	1.13e-04	2	242	2	ctd:C036676
Drug	Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; HL60; HT_HG-U133A	RTEL1 SYTL2 MPDZ BCL2L1 ACTN2 STAT2 AMPD3 PHLDA1 PPP1R16B	1.44e-04	181	242	9	2930_UP
Drug	Magnetite Nanoparticles	POGLUT3 HIVEP1 MYLK RTEL1 BCL2L1 SREK1 STAT2 GGT1 PRDM2 CFLAR S100A10 FGD4 ATP6V0D2 UTRN STRN3 AMPD3 TANK PNN PHLDA1 IFI16 PPWD1 SUV39H2 CYRIB EIF2S1 N4BP2 DDX25 OTUD4 GIGYF2 SNTA1	1.52e-04	1310	242	29	ctd:D058185
Drug	testosterone enanthate	ADAM21 MPDZ BPTF AP2B1 HTATSF1 ALDH1B1 ALDH1A3 VCP STRN3 DDX17 PHLDA1 IFI16 ESF1 FXR1 SUGP2 EIF2S1 MACF1	1.53e-04	575	242	17	ctd:C004648
Drug	ddAMP	ADAR ADSL AMPD1 AMPD3	1.55e-04	26	242	4	CID000065356
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA	RTEL1 STAT2 CFLAR NF1 KCNH2 SLC9A7 AMPD3 PHLDA1 ATP10D	1.76e-04	186	242	9	1004_UP
Drug	Se-Px	AMPD1 AMPD3 SEPHS1	1.84e-04	11	242	3	CID000159448
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	ACP6 ZSWIM8 NEB GREB1L KCNH2 POU4F1 IFI16 ATP10D PPP1R16B	1.91e-04	188	242	9	2370_UP
Drug	Succimer	POGLUT3 HIVEP1 MYLK RTEL1 BCL2L1 SREK1 STAT2 GGT1 PRDM2 CFLAR S100A10 FGD4 ATP6V0D2 UTRN STRN3 AMPD3 TANK PNN PHLDA1 IFI16 PPWD1 SUV39H2 CYRIB EIF2S1 N4BP2 OTUD4 GIGYF2 SNTA1	1.96e-04	1264	242	28	ctd:D004113
Drug	Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A	RTEL1 GIT2 STRN3 AMPD3 DSCAM PHLDA1 CPT1B CSNK1E SNTA1	1.99e-04	189	242	9	5675_UP
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	SYT12 NEB CFLAR BMPR2 UTRN DSCAM SH2B1 CSNK1E OTUD4	1.99e-04	189	242	9	1646_UP
Drug	Flavonoids	SYT12 PPP2R2D COPB2 ACTN4 BCL2L1 NUP54 S100A10 SEPTIN3 KCNH2 SPON1 TJP2 FGF8 EEF2K ECEL1 SDHA CA2 AMPD1 AMPD3 CPT1B BCO1 PPP2R2C CELSR3 EIF2S1 DDX25 ATP2A3 HTT	2.03e-04	1136	242	26	ctd:D005419
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	SYTL2 GIT2 P3H1 ARHGEF12 SUV39H2 CYRIB MACF1 UGGT2 STAG3	2.15e-04	191	242	9	4811_DN
Drug	Azathymine, 6 [932-53-6]; Down 200; 31.4uM; HL60; HT_HG-U133A	STK17A PRDM2 CFLAR NF1 HTATSF1 ALDH6A1 DDX17 ATP2A3 TXLNG	2.15e-04	191	242	9	2466_DN
Drug	Syrosingopine [84-36-6]; Up 200; 6uM; HL60; HG-U133A	NDUFB7 DENND2B CFLAR DDX17 POLG CPT1B PPP1R16B MPHOSPH6 SNTA1	2.15e-04	191	242	9	1761_UP
Drug	Metyrapone [54-36-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A	SYT12 ACTN2 NF1 AP2B1 AMPD3 DSCAM IFI16 CYRIB CLCA2	2.15e-04	191	242	9	5667_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A	PRDM2 CFLAR RHBDD3 ALDH6A1 SLC27A2 STRN3 DDX17 IFI16 OTUD4	2.24e-04	192	242	9	4274_DN
Drug	Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A	NF1 AP2B1 PHLDA1 POLG ARHGEF12 SUGP2 SMARCC2 ATP2A3 TJP3	2.24e-04	192	242	9	7427_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	ZSWIM8 SYTL2 RPP25 RHBDD3 ARHGEF12 SUV39H2 CYRIB TOE1 SUGP2	2.24e-04	192	242	9	6986_DN
Drug	Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; MCF7; HT_HG-U133A	CFLAR SEC24D NF1 KCNH2 UTRN TANK CYRIB PLA2G4C CELSR3	2.32e-04	193	242	9	2852_UP
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	NF1 KCNH2 RHBDD3 ALDH1B1 CYRIB ATP10D CSNK1E ATP2A3 STAG3	2.32e-04	193	242	9	5584_DN
Drug	Etofenamate [30544-47-9]; Up 200; 10.8uM; PC3; HT_HG-U133A	DCHS2 STK17A ADD2 KCNH6 CYRIB KMT2D CELSR3 CSNK1E CA5B	2.32e-04	193	242	9	3989_UP
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; HL60; HT_HG-U133A	ACTN1 GIT2 CFLAR ALDH6A1 AMPD3 CYRIB EIF2S1 VCAN MACF1	2.32e-04	193	242	9	2366_DN
Drug	Carcinine [56897-53-1]; Down 200; 22uM; MCF7; HT_HG-U133A	MPDZ CFLAR RHBDD3 DSCAM PHLDA1 ARHGEF12 SUGP2 STAG3 DOP1A	2.32e-04	193	242	9	3242_DN
Drug	Podophyllotoxin [518-28-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ZSWIM8 ADD2 KCNH6 NF1 CLCN1 DOCK3 MYO1F CA5B SNTA1	2.32e-04	193	242	9	6103_UP
Drug	Trifluridine [70-00-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	DCAF1 ZSWIM8 RTEL1 GIT2 NF1 KCNH2 ALDH1B1 CPT1B TJP3	2.32e-04	193	242	9	7176_UP
Drug	Antimycin A [1397-94-0]; Down 200; 7.2uM; PC3; HT_HG-U133A	RPP25 BPTF SLC27A2 GPATCH1 ZNF254 ARHGEF12 IFI16 CSNK1E MAST3	2.32e-04	193	242	9	2098_DN
Drug	C75; Down 200; 10uM; MCF7; HT_HG-U133A	MAP2 RTEL1 PYHIN1 DOCK3 BCO1 MYO1F CA5B ATP2A3 DOP1A	2.32e-04	193	242	9	6394_DN
Drug	Verdict	BCL2L1 ADAR NF1 MLH1	2.40e-04	29	242	4	CID000050896
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	DCAF1 RTEL1 GIT2 CFLAR NF1 AP2B1 ALDH1B1 ATP8B2 MYO1F	2.42e-04	194	242	9	7481_DN
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	MAP2 RTEL1 CDK14 PTPRM KCNH2 CLCA2 MYO1F ATP2A3 MAST3	2.42e-04	194	242	9	4961_UP
Drug	Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A	SLC27A2 TTF2 STRN3 DDX17 PHLDA1 ARHGEF12 IFI16 FXR1 OTUD4	2.42e-04	194	242	9	4272_DN
Drug	Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; HL60; HT_HG-U133A	PPP1R12B SPTB DGKG BCL2L1 ACTN2 NF1 DSCAM CSNK1E TJP3	2.42e-04	194	242	9	2391_UP
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A	DCAF1 BRIP1 MYLK SYTL2 BCL2L1 ACTN1 PHLDA1 ZNF254 VCAN	2.42e-04	194	242	9	2086_DN
Drug	Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A	MAN2C1 NEB NF1 AP2B1 GPC4 ALDH1B1 SASH1 DSCAM PHLDA1	2.42e-04	194	242	9	3454_DN
Drug	hydride	SP2 CYP2A6 CYP2A13 ATP6V0A1 CYP8B1 GALP NDUFB7 GUF1 DHDH AP2B1 SLC9A7 ATP6V0D2 ALDH1B1 ALDH1A3 ALDH6A1 SDHA CA2 SLC27A2 DOCK3 VCAN ATP2A3	2.47e-04	835	242	21	CID000000783
Drug	(R)-Propranolol hydrochloride [13071-11-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A	RGS9 NEB PYHIN1 NF1 UTRN PHLDA1 BCO1 CLCA2 CA5B	2.51e-04	195	242	9	3553_UP
Drug	Flufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A	BRIP1 MAN2C1 MPDZ GIT2 CDK14 DENND2B TANK POLG ZNF254	2.51e-04	195	242	9	2104_DN
Drug	Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A	ATP6V0A1 NEB DENND2B NF1 KCNH2 RHBDD3 ZNF254 ATP8B2 SH2B1	2.51e-04	195	242	9	5388_DN
Drug	CAY10397; Up 200; 10uM; PC3; HT_HG-U133A	ACVR2A CFLAR BMPR2 SLC27A2 FPGS ARHGEF12 CYRIB SNTA1 HTT	2.51e-04	195	242	9	7087_UP
Drug	Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; MCF7; HT_HG-U133A	BCL2L1 ACTN2 CDK14 AP2B1 AMPD1 AMPD3 SH2B1 PLA2G4C ATP2A3	2.51e-04	195	242	9	2245_DN
Drug	LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A	BCL2L1 KCNH2 RHBDD3 ALDH1B1 DDX17 DSCAM CCDC186 SUGP2 MYO1F	2.51e-04	195	242	9	5213_DN
Disease	focal segmental glomerulosclerosis 1 (implicated_via_orthology)	ACTN4 ACTN1 ACTN2	5.12e-06	5	238	3	DOID:0111128 (implicated_via_orthology)
Disease	pontocerebellar hypoplasia (implicated_via_orthology)	AMPD1 AMPD3 TOE1	5.12e-06	5	238	3	DOID:0060264 (implicated_via_orthology)
Disease	aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology)	GGT1 GGT3P GGT2P	1.77e-05	7	238	3	DOID:5022 (biomarker_via_orthology)
Disease	alcohol dependence (biomarker_via_orthology)	GGT1 GGT3P GGT2P	2.82e-05	8	238	3	DOID:0050741 (biomarker_via_orthology)
Disease	pallidum volume	SYTL2 BCL2L1 BIRC6 HS3ST4	4.57e-05	25	238	4	EFO_0006933
Disease	Adenosine monophosphate deaminase deficiency	AMPD1 AMPD3	6.48e-05	2	238	2	C2931781
Disease	Muscle AMP deaminase deficiency	AMPD1 AMPD3	6.48e-05	2	238	2	C0268123
Disease	colorectal cancer	RTEL1 UBAC1 MLH1 PLCL1 HS3ST4 DOCK3 AMPD3 GPATCH1 LAMC1 CYRIB SCMH1 VCAN TPH2 MACF1 PCNT	1.29e-04	604	238	15	MONDO_0005575
Disease	Malignant neoplasm of breast	BRIP1 MAN2C1 PPP1R12B OBSCN DGKG ADAR BMPR2 NF1 CLCN1 OTOF NLRC5 DLEC1 TANK SUV39H2 KMT2D FXR1 CLCA2 N4BP2 MACF1 ATP2A3 DOP1A	1.81e-04	1074	238	21	C0006142
Disease	short QT syndrome (implicated_via_orthology)	KCNH6 KCNH2	1.93e-04	3	238	2	DOID:0050793 (implicated_via_orthology)
Disease	Colorectal Carcinoma	PCSK2 CYP2A6 MAP2 OBSCN ABCA10 NF1 KCNA10 MLH1 UGT3A2 RIC3 AMPD1 RELCH FPGS ABCC5 LAMC1 VRTN	2.05e-04	702	238	16	C0009402
Disease	cognitive function measurement	DENND4A HIVEP1 GBF1 PPP2R2D GON7 DPP8 NREP BIRC6 SEPTIN3 FGD4 SYT4 FGF8 UGT3A2 PLCL1 ATP6V0D2 TAF2 DOCK3 DSCAM ABCC5 SH2B1 STRIP1 KMT2D SCMH1 GIGYF2 BZW1	2.59e-04	1434	238	25	EFO_0008354
Disease	response to non-steroidal anti-inflammatory, drug-induced liver injury	SYTL2 CAMTA1	3.85e-04	4	238	2	EFO_0004228, EFO_0005533
Disease	attention deficit hyperactivity disorder, autism spectrum disorder, intelligence	GBF1 PPP2R2D DPP8 NREP ITIH3 SEPTIN3 FGF8 PLCL1 TANK KMT2D MAST3	4.22e-04	398	238	11	EFO_0003756, EFO_0003888, EFO_0004337
Disease	monocyte count	ASXL1 DENND4A HIVEP1 CYP8B1 BCL2L1 ACVR2A DPP8 NREP DENND2B EHD4 NF1 ADSL TMTC3 FGD4 NLRC5 ALDH1B1 VCP TTF2 ARHGEF12 GCSAML KLHL5 VCAN SLC7A10	4.62e-04	1320	238	23	EFO_0005091
Disease	Nonsyndromic Deafness	BDP1 TJP2 PJVK MYO1F OTOG	5.09e-04	81	238	5	C3711374
Disease	neuroimaging measurement, brain volume measurement	ACTN4 BCL2L1 BPTF NF1 STRN3 GPATCH1 LAMC1 SH2B1 VCAN	5.60e-04	286	238	9	EFO_0004346, EFO_0006930
Disease	3-hydroxylaurate measurement	S100A10 OTOF	6.38e-04	5	238	2	EFO_0800204
Disease	cholangiocarcinoma, sclerosing cholangitis	DOCK3 CABCOCO1	6.38e-04	5	238	2	EFO_0004268, EFO_0005221
Disease	immunoglobulin superfamily DCC subclass member 4 measurement	DENND4A DPP8	6.38e-04	5	238	2	EFO_0801690
Disease	diverticular disease	NREP S100A10 NF1 KCNH2 DLEC1 DOCK3 PPP1R16B CABCOCO1	6.99e-04	236	238	8	EFO_0009959
Disease	Hereditary Paraganglioma-Pheochromocytoma Syndrome	NF1 SDHA KMT2D	8.14e-04	23	238	3	C1708353
Disease	red blood cell density measurement	POGLUT3 DENND4A HIVEP1 EXOC3 BCL2L1 DPP8 NREP DENND2B ITIH3 TMTC3 TJP2 CAMTA1 DNAH2 LAMC1 ATP8B2 OTUD4 SLC7A10	8.55e-04	880	238	17	EFO_0007978
Disease	diacylglycerol 34:1 measurement	PYHIN1 ZNF254 BUD13	9.25e-04	24	238	3	EFO_0010352
Disease	glucagon measurement, glucose tolerance test	SPON1 MACF1	9.51e-04	6	238	2	EFO_0004307, EFO_0008463
Disease	Lissencephaly	TMTC3 MACF1	9.51e-04	6	238	2	C0266463
Disease	long QT syndrome (is_implicated_in)	KCNH2 SNTA1	1.32e-03	7	238	2	DOID:2843 (is_implicated_in)
Disease	apolipoprotein A 1 measurement	CYP2A6 DGKG BCAT2 NREP ADAR BMPR2 SPON1 NLRC5 SYT4 DLEC1 AMPD3 RAB25 BUD13 LAMC1 MACF1 SLC7A10	1.54e-03	848	238	16	EFO_0004614
Disease	brain measurement, neuroimaging measurement	DCHS2 MAP2 ACTN4 MOB2 DNAAF3 BPTF TANK GPATCH1 LAMC1 PPWD1 VCAN MACF1	1.82e-03	550	238	12	EFO_0004346, EFO_0004464
Disease	neutrophil count	POGLUT3 DENND4A HIVEP1 PPP2R2D CYP8B1 DGKG DPP8 ADAR DENND2B EHD4 ADSL SLC9A7 NLRC5 OSCP1 PLCL1 ATP6V0D2 DSCAM ARHGEF12 ABCC5 IFI16 HTT PCNT	1.95e-03	1382	238	22	EFO_0004833
Disease	leukodystrophy (implicated_via_orthology)	SDHA EIF2S1	2.25e-03	9	238	2	DOID:10579 (implicated_via_orthology)
Disease	Major depression, single episode	S100A10 HSPA1L	2.25e-03	9	238	2	C0024517
Disease	PR interval	PCNX3 OBSCN NREP ELMO1 DNAAF3 BMPR2 DLEC1 CAMTA1 LAMC1 MACF1 MICU2	2.43e-03	495	238	11	EFO_0004462
Disease	long QT syndrome (implicated_via_orthology)	KCNH6 KCNH2	2.79e-03	10	238	2	DOID:2843 (implicated_via_orthology)
Disease	Adenoma, Microcystic	BCL2L1 NF1 ATP2A3	3.04e-03	36	238	3	C0205648
Disease	Adenoma, Monomorphic	BCL2L1 NF1 ATP2A3	3.04e-03	36	238	3	C0205649
Disease	Adenoma, Basal Cell	BCL2L1 NF1 ATP2A3	3.04e-03	36	238	3	C0205646
Disease	Follicular adenoma	BCL2L1 NF1 ATP2A3	3.04e-03	36	238	3	C0205647
Disease	Papillary adenoma	BCL2L1 NF1 ATP2A3	3.04e-03	36	238	3	C0205650
Disease	Adenoma, Trabecular	BCL2L1 NF1 ATP2A3	3.04e-03	36	238	3	C0205651
Disease	Adenoma	BCL2L1 NF1 ATP2A3	3.04e-03	36	238	3	C0001430
Disease	methylcobalamin deficiency type cblE	ABCA10 HS3ST4 ZNF254 CABCOCO1	3.05e-03	74	238	4	MONDO_0009354
Disease	Malignant neoplasm of stomach	CYP2A6 BCL2L1 DDB1 MLH1 ATP6V0D2 ALDH1A3 CA2 ACAD8	3.16e-03	300	238	8	C0024623
Disease	serum gamma-glutamyl transferase measurement	CYP2A6 BRIP1 SYT12 PCNX3 BCAT2 DENND2B GGT1 BPTF NF1 PTPRM MLH1 SLC9A7 GPATCH1 APIP MAST3 TJP3	3.23e-03	914	238	16	EFO_0004532
Disease	diastolic blood pressure, systolic blood pressure	BRIP1 DENND2B EHD4 MOB2 SPON1 SYT4 RHBDD3 DLEC1 TAF2 DNAH2 DNAH7 CLCA2 N4BP2	3.29e-03	670	238	13	EFO_0006335, EFO_0006336
Disease	loneliness measurement	HIVEP1 BPTF PLCL1 UTRN MACF1	3.39e-03	124	238	5	EFO_0007865
Disease	gastric adenocarcinoma (is_implicated_in)	RTEL1 KMT2D	3.40e-03	11	238	2	DOID:3717 (is_implicated_in)
Disease	Congenital long QT syndrome	KCNH2 SNTA1	3.40e-03	11	238	2	cv:C1141890
Disease	household income	GBF1 PPP2R2D DNAAF3 FGF8 PLCL1 TANK STX10 HTT	3.42e-03	304	238	8	EFO_0009695
Disease	puberty onset measurement	BIRC6 PRDM2 PLCL1 CAMTA1 DOCK3	3.50e-03	125	238	5	EFO_0005677
Disease	Intellectual Disability	TBC1D20 BPTF NF1 ADSL TAF2 CA2 KIF7 SMARCC2 MACF1 HTT	3.60e-03	447	238	10	C3714756
Disease	thioredoxin domain-containing protein 12 measurement	DCAF1 DOCK3 CELSR3	3.82e-03	39	238	3	EFO_0008298
Disease	hypospadias	EXOC3 DENND2B DGKK	3.82e-03	39	238	3	EFO_0004209
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	PPP2R2D PPP2R2C	4.05e-03	12	238	2	DOID:1441 (implicated_via_orthology)
Disease	intracranial aneurysm (is_implicated_in)	KMT2D VCAN	4.05e-03	12	238	2	DOID:10941 (is_implicated_in)
Disease	Long QT syndrome	KCNH2 SNTA1	4.05e-03	12	238	2	cv:C0023976
Disease	neutrophil percentage of leukocytes	DENND4A HIVEP1 ELMO1 EHD4 TMTC3 SLC9A7 NLRC5 ALDH1B1 AMPD3 IFI16 SLC7A10 HTT	4.20e-03	610	238	12	EFO_0007990
Disease	platelet measurement	ACTN4 ACTN1 NREP ELMO1 AP2B1 FGD4 ALDH1B1 GCSAML	4.23e-03	315	238	8	EFO_0005036
Disease	macula measurement	DCHS2 STAT2 BPTF TJP2 LRIT2 ZNF488	4.44e-03	189	238	6	EFO_0008375
Disease	rectum cancer	DLEC1 PLCL1 LAMC1	4.72e-03	42	238	3	EFO_1000657
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP1 ACVR2A	4.77e-03	13	238	2	DOID:0050787 (implicated_via_orthology)
Disease	whole-brain volume, Alzheimer's disease biomarker measurement	ADD2 MICU2	5.53e-03	14	238	2	EFO_0005089, EFO_0006514
Disease	triacylglycerol 48:4 measurement	DSCAM MPHOSPH6	5.53e-03	14	238	2	EFO_0010407
Disease	colorectal cancer, hormone replacement therapy	HIVEP1 CAMTA1 SASH1 CPT1B	5.67e-03	88	238	4	EFO_0003961, MONDO_0005575
Disease	mean reticulocyte volume	POGLUT3 BRIP1 STK17A SPTB DPP8 NEB NREP TMTC3 AP2B1 DNAH2 SH2B1 CYRIB OTUD4 SLC7A10	5.68e-03	799	238	14	EFO_0010701
Disease	memory performance	DENND4A ACTN2 NEB ITIH3 DNAAF3 SYT4 PHLDA1 ARHGEF12 N4BP2	6.25e-03	409	238	9	EFO_0004874
Disease	Muscular Atrophy	KCNH2 AMPD1	6.35e-03	15	238	2	C0026846
Disease	Down syndrome (implicated_via_orthology)	DSCAM DOP1A	6.35e-03	15	238	2	DOID:14250 (implicated_via_orthology)
Disease	myelodysplastic syndrome (implicated_via_orthology)	ASXL1 POLG	6.35e-03	15	238	2	DOID:0050908 (implicated_via_orthology)
Disease	Neurogenic Muscular Atrophy	KCNH2 AMPD1	6.35e-03	15	238	2	C0270948
Disease	neuroticism measurement, cognitive function measurement	ASXL1 HIVEP1 PPP1R12B ACVR2A NREP BIRC6 PLCL1 TANK DSCAM N4BP2 MAST3	6.57e-03	566	238	11	EFO_0007660, EFO_0008354
Disease	hemorrhoid	BRIP1 ACVR2A BIRC6 NF1 AMPD3	6.92e-03	147	238	5	EFO_0009552
Disease	coronary thrombosis, GM11992	DSCAM GPATCH1	7.22e-03	16	238	2	EFO_0001124, EFO_1000883
Disease	Romano-Ward Syndrome	KCNH2 SNTA1	7.22e-03	16	238	2	C0035828
Disease	fourth ventricle volume measurement	ADD2 ATP10D	7.22e-03	16	238	2	EFO_0010303
Disease	acute myeloid leukemia (is_marker_for)	BCL2L1 CFLAR NF1	7.26e-03	49	238	3	DOID:9119 (is_marker_for)
Disease	schizophrenia, intelligence, self reported educational attainment	DCAF1 DENND4A AP2B1 PLCL1 SH2B1 FXR1 PPP1R16B GIGYF2	7.33e-03	346	238	8	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	Squamous cell carcinoma of esophagus	CYP2A6 DLEC1 CA2 KMT2D	7.41e-03	95	238	4	C0279626
Disease	mean fractional anisotropy measurement	MOB2 CAMTA1 STRN3 VCAN	7.41e-03	95	238	4	EFO_0008399
Disease	myocardial infarction	BRIP1 DENND2B RPP25 SEC24D SASH1 LAMC1 GIGYF2 HTT	7.83e-03	350	238	8	EFO_0000612

Protein segments in the cluster

Peptide	Gene	Start	Entry
PLQFEEMIDRLEKGS	EPC1	136	Q9H2F5
REQEREGDPMANFIK	BUD13	536	Q9BRD0
RSFNIVDIKPANMED	PPP2R2C	206	Q9Y2T4
EIDQTENVKPMLRGR	BDP1	601	A6H8Y1
GEKEKRMVDNFRPLQ	CA5B	271	Q9Y2D0
DNFPQVDKAMLIERI	CCDC186	751	Q7Z3E2
RIKQENFVPMESSGL	CAMTA1	1411	Q9Y6Y1
FLKAPDERRQEMANI	ELMO1	251	Q92556
TKMDPQDQAQRDIIF	ELMO1	311	Q92556
PQGEAEFARIMSIVD	ACTN1	786	P12814
EAEFARIMTLVDPNG	ACTN2	791	P35609
ILDTEMKRLDQEQGP	CABCOCO1	131	Q8IVU9
PLNVLFVEDGKMERQ	AP2B1	821	P63010
EPIEDMQLTSKNGFE	BIRC6	876	Q9NR09
FNRMENVAKEVGPLV	VCAN	2301	P13611
FLIRMQEEEKNPNTE	CYP2A6	271	P11509
GNEIMNKDPVFRISP	ABCA10	1141	Q8WWZ4
ELFPVDVMRKAAQLG	ACAD8	71	Q9UKU7
LQEQMSRGDPFKDII	BZW1	261	Q7L1Q6
EEMVDARKNLPRAIF	SLC7A10	256	Q9NS82
KFMPSGELCRQEVNE	ADAM21	456	Q9UKJ8
LVTPNEERNVMEEGK	COPB2	826	P35606
EERNVMEEGKDFQPS	COPB2	831	P35606
SPMEARDKAQFLQDI	IQCD	201	Q96DY2
VQDDMRIAKEEIFGP	ALDH1B1	406	P30837
MAPEVLEGAINFQRD	ACVR2A	366	P27037
QGEAEFNRIMSLVDP	ACTN4	806	O43707
VTDNMRIAKEEIFGP	ALDH1A3	401	P47895
IPMAAVKQALREAGD	BCL2L1	81	Q07817
RSFNIVDIKPANMEE	PPP2R2D	216	Q66LE6
FGEENTLMQDLKPFR	DOP1A	341	Q5JWR5
SDGPVTVQEFMEVKN	GIT2	421	Q14161
FIDRSLKEQPMDDNI	ADAM32	156	Q8TC27
LPAEEKQIDDAMRNF	AMPD1	6	P23109
AFPGMKDIQDQLERI	CDK14	331	O94921
QMREAEERLKAIPQF	DENND2B	731	P78524
SAIRPFINGDVIMED	BPTF	1586	Q12830
SLLEVDGPAMKNVEF	CFLAR	371	O15519
KGLAFNMIEVDELPS	DDX25	441	Q9UHL0
ELGKIRSQMAAVEPE	ATP2A3	231	Q93084
QMKRNRGEEIDFETP	ASXL1	241	Q8IXJ9
PDGASLEKQQMIVRE	ATP10D	811	Q9P241
PVFVQSVKEDGAAMR	ARHGEF12	91	Q9NZN5
MPRQFPKLNISEVDE	AMPD3	1	Q01432
ELDGETNMKVRQAIP	ATP8B2	186	P98198
RVLFEMQKAGIDPNA	DENND4A	831	Q7Z401
PTEEARMFAENNGLL	RAB25	136	P57735
MRQNIVLPSDEKGEL	OTUD4	876	Q01804
EALVKDMQNPETGVR	RGS9	21	O75916
KDMVTELFDPLVQGE	GON7	41	Q9BXV9
DRVQADDLVKMLFSP	P3H1	686	Q32P28
EKLDMSRFPVENIRN	GUF1	56	Q8N442
AREFNLLDPKETAIM	MOB2	186	Q70IA6
ERVKMQLASFLEDPQ	RELCH	1041	Q9P260
GDPKFVDVTEVVRNM	GGT3P	331	A6NGU5
EVIGRVPQATKAEMD	ALDH6A1	66	Q02252
VSQEPFPNKDMEGRL	NREP	11	Q16612
AEGAQREKMNKPELF	POU4F1	336	Q01851
DIMPGLETAVVFQEK	DCAF1	111	Q9Y4B6
KGQVEMDVPRFEAAA	DGKK	631	Q5KSL6
KEIPAEQMDFRANLQ	MYLK	916	Q15746
MQVIFGIDVKEVDPA	MAGEA8	161	P43361
LGDMFSPIRDDAVVN	NEDD1	406	Q8NHV4
EFKQVRIENSPLFEM	LRIT2	56	A6NDA9
LMVAERLEGPFNIES	GPC4	296	O75487
DNENKLPREDGMVPF	FXR1	321	P51114
KIEEKRGVFNVQMEP	EIF2S1	261	P05198
RGVFNVQMEPKVVTD	EIF2S1	266	P05198
DVVPVKNEDGAVIMF	KCNH2	111	Q12809
DVVPVKNEDGAVIMF	KCNH6	111	Q9H252
FGEDVPNRLVDNIDM	BEX5	46	Q5H9J7
PSEFGKERMKEEQVQ	ESF1	386	Q9H501
QNRADKSVLGPEDFM	GPATCH1	81	Q9BRR8
SFPIQKMQIDEREEF	GPATCH1	816	Q9BRR8
FGFNQVSELLPRMED	PCNX3	141	Q9H6A9
RIEFAEQINKMEARP	PNN	271	Q9H307
LLEEANRGSFPAEMV	FGD4	236	Q96M96
LVMGNGKVVEFDRPE	ABCC11	1346	Q96J66
NAPVTEEDLRNLMFG	DNAH12	2171	Q6ZR08
AEAKMENLRAAVPGQ	POLG	701	P54098
EQGIVPRAMAEAFKL	KIF7	116	Q2M1P5
IGRKFNDPVVQADMK	HSPA1L	76	P34931
ISAGDFPEVKAMQEQ	EHD4	351	Q9H223
ETEAAMEKLINRVGP	RIC3	156	Q7Z5B4
SVIKEEAANRDGPMI	PTPRZ1	2206	P23471
KMQQRRGDSVVTPFD	GREB1L	626	Q9C091
ARQEEIKMEGVEPNS	KLHL5	256	Q96PQ7
FEKEQEMQGVELQPR	PCNT	2461	O95613
QEMEGSDKPQELARV	ECEL1	426	O95672
FPERKEREMVATQQE	NDUFB7	31	P17568
QKGPQERAAFLDSLM	NLRC5	951	Q86WI3
EGFMEENQTKLSPRE	MACF1	3681	Q9UPN3
RDSGVNSKLQFEIMP	DCHS2	1751	Q6V1P9
PEVVGNFNRNEKCME	BRIP1	286	Q9BX63
FGIIMRDPQTEEFKV	HTATSF1	156	O43719
AMPSKFIEGLRNEEA	OBSCN	3711	Q5VST9
MPSNKDEDGLVVLVF	NUP54	181	Q7Z3B4
GITQEKINEMRVAPE	PPP1R16B	191	Q96T49
QFPETLLGDREKRMQ	KCNA10	106	Q16322
SKDMDEVDVRLPFQA	ABCC5	976	O15440
PLKLESEVMENGDNF	ABCC5	1316	O15440
DPERKGSLSNLMDFV	PLA2G4C	331	Q9UP65
INAMAEDGDPFAKLI	FGF8	91	P55075
LETGRPQDKLEFMFR	DGKG	171	P49619
RNVMETFAKPEIGDL	GALP	86	Q9UBC7
KGNPDEERKRQEMTT	GCSAML	21	Q5JQS6
FIVVPNGKEQRMKDE	CKAP5	1161	Q14008
RNSPEFQKLLGIAME	HTT	116	P42858
FLIRMQEEEKNPNTE	CYP2A13	271	Q16696
DVLQMDRVPDRVKSF	DOCK3	1431	Q8IZD9
PEKMGLQERSETFLE	DNAAF3	101	Q8N9W5
NEKAERMGFTEVTPV	ADAR	796	P55265
KVPSRGDEMVADVQQ	GIGYF2	421	Q6Y7W6
RVPEAEDLASQMLKG	CDK15	356	Q96Q40
EEPQVEQLGSKRMDS	C6orf47	76	O95873
VAMQAEKFPSEPNRL	DPP8	811	Q6V1X1
TFQKRDLPQMMDEVG	DDX11L8	676	A8MPP1
SQMPEEGRRFTAVDK	DNAH7	1001	Q8WXX0
LDEKLLARGTMQPFN	FEM1A	621	Q9BSK4
IQIADLMEEKFPGDA	PYHIN1	46	Q6K0P9
FEDMQVLVSREKQRP	BMPR2	446	Q13873
QFRPEVSMDGCKVQD	COL27A1	1801	Q8IZC6
ADVNADRNMEIPKGL	IFI16	651	Q16666
DPEKMFQLSRAELAV	MAN2C1	166	Q9NTJ4
PKATAQMEGRLQEFL	MAST3	181	O60307
KQPMPAAGELEERFN	FMNL1	26	O95466
EKPTGVNAAEVREMV	DHDH	96	Q9UQ10
KRQRGDPQTQLEAME	FPGS	66	Q05932
AMIEVEDFVDPNGKI	GBF1	1046	Q92538
GDPNNMTLLAEEARK	LAMC1	1171	P11047
RFDELKMTNPAIQND	CYRIB	141	Q9NUQ9
DDEVLIKMASQPFGR	EEF2K	126	O00418
LDMGFEPQIRKIVDQ	DDX17	331	Q92841
VLDVNDNRPEFTMKE	CELSR3	746	Q9NYQ7
VAGMLQRPDQLDKVE	EXOC3	16	O60645
TMENGPELILRFQKE	BCAT2	361	O15382
TMKRDPTAEQFQEEL	CASP14	51	P31944
TIDQAQKEPAMRFGT	DLEC1	1251	Q9Y238
IAMLSPDEQALFKER	DNAH2	686	Q9P225
KPMEGNFEEIARDFN	DDB1	936	Q16531
IVDPAGEMAKVQDFL	HS3ST4	361	Q9Y661
FLREQGVPSAMQDKF	CYP8B1	261	Q9UNU6
KPQDLEMQFQRILDD	CPT1B	356	Q92523
GDPKFVDVTEVVRNM	GGT2P	331	P36268
DFVEMRKNDPQSITA	MCMBP	576	Q9BTE3
MQIPRTKEEANGDVF	PRDM2	341	Q13029
MIDRRNGDKPITFEV	OTOF	621	Q9HC10
LMNPEGRKESQELIV	PTPRM	461	P28827
GNFDLKTINEMRTPE	OTOG	1116	Q6ZRI0
SGVQKERIQPEDMFV	APIP	61	Q96GX9
MENFRKVRSEEAPAG	RPP25	1	Q9BUL9
DNMPLELSGRFQKTV	DSCAM	261	O60469
LLMSRVVPGQFDDAD	RIOK1	6	Q9BRS2
EPVAGAQTDRAKLFM	RTEL1	886	Q9NZ71
VVNIKEARGLPAMDE	SYT4	171	Q9H2B2
PVALEAENRGEMKLA	SYTL2	761	Q9HCH5
VKRDDPNPVFNEAMI	SYT12	341	Q8IV01
FKEVAGPTEMCDQRQ	UTRN	2976	P46939
EMPDRENTFVVKVEG	SH2B1	336	Q9NRF2
LNQGDLKMPTFESEE	STRN3	141	Q13033
ELGSPVKMEEEIRQQ	SPON1	261	Q9HCB6
KVRQFALAMPEATGD	CARS2	496	Q9HA77
LRQPFEKLQMSSDDG	SNTA1	446	Q13424
FRNCVKIEEIMPNGD	STAT2	806	P52630
LLQMLEEDQAGFRIP	PIH1D1	86	Q9NWS0
PNAGEESVMNLDKLR	SDHA	486	P31040
SFRGFNPEVEKLMLQ	MPHOSPH6	76	Q99547
MTLVEEGFNPAVIKD	SLC27A2	576	O14975
DPDMSVLRKVEFEQA	TAF2	631	Q6P1X5
PENLQEARTFVKSME	ITIH3	341	Q06033
FPEENTRMRKVVQAE	FSD2	36	A1L4K1
EEVMAATQAEGPKRV	PPWD1	476	Q96BP3
KEMEEPFEKQQIGSS	ADSL	276	P30566
KEPEINTTLQMRFFG	MICU2	226	Q8IYU8
MPLIIQGFKDAAEEA	SEPHS1	141	P49903
SVLGQRVDLPEDFQM	STRIP1	801	Q5VSL9
LRKLPTMAEVNGEQD	SIMC1	11	Q8NDZ2
MEFRDNPGNFVKTEE	TANK	271	Q92844
QDLPQFVDKIRGEGM	SI	1276	P14410
GEVKFVRMAGDETQP	SREK1	91	Q8WXA9
LLEDMPQIFGEQVSR	KCTD14	121	Q9BQ13
AGEVIQRPANAIKEM	MLH1	21	P40692
EVPGLIRMFNNKGEE	OSCP1	211	Q8WVF1
KEKPTDMQNFGLRTD	SMARCC2	566	Q8TAQ2
PEMVFRQFLVEDKGL	SEC24D	996	O94855
LRVLMEKEFPGFLEN	S100A10	31	P60903
IQEPSFRMEKALEEA	STK17A	326	Q9UEE5
EDVMQFVREADPQLG	SCMH1	596	Q96GD3
MDIIFGRNRKEQLEP	BCO1	1	Q9HAY6
PSFREELEGLIQEQM	ADD2	61	P35612
RKLNFNGEGEPEELM	CA2	226	P00918
SPMEAQEFGILDKVL	CLPP	231	Q16740
IQMNAPRKSVGRNEE	CLCA2	721	Q9UQC9
KEQFSDREQDIGMPK	CLCN1	66	P35523
QDPDGTRKLLNFMLD	CNOT6L	146	Q96LI5
QLERMGFPTEQAVVA	RHBDD3	331	Q9Y3P4
QQMLKEVPKRFGDER	POGLUT3	176	Q7Z4H8
PELQEAEVFIMDNKR	PRSS45P	136	Q7RTY3
LVSRSKQPLDFMEGN	PLCL1	221	Q15111
AFTELPRMKDRQVDA	ZNF488	101	Q96MN9
FGPIADIAMEKLANE	TJP2	736	Q9UDY2
ENIIDESGMPKERFS	TRBV18	71	A0A087X0M5
LPGDRLMFVNDVNLE	MPDZ	746	O75970
SGQPEEELNRLMKFD	MRAP2	151	Q96G30
EELNRLMKFDIPNFV	MRAP2	156	Q96G30
FMDEQNPKGRDKAIV	PJVK	186	Q0ZLH3
QGLNELPAFIEMRDL	STAG3	946	Q9UJ98
LSQPKMDELQLFRGD	VCP	41	P55072
MAEGKEIDFRCPQDQ	PHLDA1	256	Q8WV24
NDKIRQESMPFAVVG	SEPTIN3	251	Q9UH03
PAGDLQERKVFVERM	STX10	81	O60499
MEQALAGETQPGEKR	SP2	486	Q02086
KGMIFVENTVDLEGP	SUV39H2	151	Q9H5I1
PRVDNEFLNMLLDKG	SUGP2	396	Q8IX01
FNDKSPEEVFMAIRN	NF1	2351	P21359
TKEGVDAEQRMQPKI	SASH1	966	O94885
DIDMPGQNFDSKRRI	SLU7	246	O95391
KEDRESLQMAVGPFL	ACP6	291	Q9NPH0
RKEELGELFAQVPSM	SPTB	1431	P11277
MTRNVVRQEFEAPGK	nan	1	Q96IR3
KDLSQEFGMPLSQEE	nan	391	Q6ZUG5
NVPQLEDVSMFLKER	TPH2	256	Q8IWU9
DVQMEFIQGPKEESK	MAP2	1191	P11137
EIRKANIPIMDTGEN	ATP6V0A1	71	Q93050
ILRKTQQFFDEMADP	ATP6V0A1	131	Q93050
EEIRQMLQGKPLADT	WRNIP1	216	Q96S55
DLFAGLKPLEQESRM	ZSWIM8	756	A7E2V4
PGEEMELVTQRKQDI	TJP3	451	O95049
MSVEFEELLKARENP	SF3A3	106	Q12874
KDFELASAQQRPDMV	TBC1D20	326	Q96BZ9
EVGEALQMNPRDFKE	TSTD3	71	H0UI37
QDIPAIFREGMKNTS	ZNF280C	156	Q8ND82
TEMGFPENRATKALQ	UBAC1	201	Q9BSL1
RFVLEPELMSGANDV	UGGT2	1016	Q9NYU1
QNIAVDSGMPKERFT	TRBV17	71	A0A087X0K7
FGDQPENMVRVEAKK	UGT3A2	391	Q3SY77
FERILEMDPSNVQGK	TMTC3	761	Q6ZXV5
SVEQNDMLRKVTFDP	SLC9A7	166	Q96T83
QEKEAGRDVTAVMAP	VRTN	576	Q9H8Y1
PRQKFEIGTMEEAGI	TXLNG	31	Q9NUQ3
EPLDGVMLEKDVFSQ	HIVEP1	1806	P15822
DPQELQKALTTMGFR	SRI	121	P30626
NDLEMGIKAARPEIA	TOE1	401	Q96GM8
PEQGMEDSFQKAILR	ZNF254	96	O75437
ERRLGQPELKAEQQM	TXNRD3NB	6	Q6F5E7
GSVNPKQRMDLVEAF	TTF2	1041	Q9UNY4
PLGRFTEMEAVNIAE	ATP6V0D2	131	Q8N8Y2
GDPKFVDVTEVVRNM	GGT1	331	P19440
NMLKFGAARNPEDVD	CSNK1E	291	P49674
EFMEQLGTALRPDKV	KMT2D	5011	O14686
EQAFLRMLFPEKLDG	MYO1F	536	O00160
QRQEEVSCGKFMQDP	N4BP2	1431	Q86UW6
MDIRNKLGQTPFDVA	PPP1R12B	276	O60237
PEMERVKRNQENFSS	NEB	6261	P20929
RDPRVKMALQQEGFD	PCSK2	91	P16519